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ABSTRACT
A comparative study of two susceptible species, the chicken and the rat, 
to crude and partially purified extracts of the plant Sesbania drummondii was 
undertaken. Partial physical and chemical characterization of crude sesbania 
extracts has been accomplished including temperature and pH stability, 
molecular weight fractionation and high pressure liquid chromatography and 
thin layer chromatography retention times. The toxicity of these different 
fractions could be differentiated with respect to weight loss, mortality, morbidity, 
serum protein changes and effect on PChE (Pseudocholinesterase) activities. 
The results indicated that more than one toxin exists in crude extracts of this 
plant. The pathophysiological findings could not be attributed to the presence of 
sesbanimide as the only major toxin of sesbania. The effects of sesbania 
extracts on serum protein concentration and PChE activity were similar but not 
identical to the effects of the protein synthesis inhibitor, cycloheximide. 
Additional qualitative and quantitative differences between the effects of 
sesbania extracts and cycloheximide were noted following histological and 
electron microscopic examination. The results suggested that inhibition of 
protein synthesis is not the only mechanism of sesbania intoxication. Some 
evidence was obtained to indicate that inhibition of export protein release from 
the liver occurred during sesbania intoxication. Further investigation suggested 
that the liver is a major target organ, though not the sole target organ, in an 
experimentally induced episode of sesbania intoxication. Phenobarbital gave 
partial protection against sesbania-induced weight loss and morbidity in the 
adult chicken but failed to protect the immature birds. No protective influence 
was noted for phenobarbital pretreatment in the sesbania treated rat. Evidence 
was obtained for the presence of several new microsomal glutathione-S- 
transferase isozymes which could be modified by sesbania treatment. 
Glutathione peroxidase activities were depressed by sesbania treatment. The 
induction of the cytochrome P-450 monooxygenase system by sesbania 
treatment in the chicken but not the rat suggested further species differences. 
The induction of the microsomal monooxygenase system and glutathione-S- 
transferases suggested the possibility of the release of free radicals or strong 
electrophiles by crude extracts of sesbania.
GOALS AND RATIONALE
Intoxication of cattle by Sesbania d rum m ond ii is a frequent 
and serious problem in Louisiana. It has been previously shown that 
most animal species are susceptible to the actions of this plant 
although there may be quantitative d ifferences in response. A 
comparison of two susceptible species (chickens and rats) will be 
undertaken to evaluate differences in response between avian and 
mammalian species.
This study has two major postulates. The first is that sesbania 
induced toxicity is the result of the presence of multiple toxins. The 
experimental approach to this problem will include a description of 
some of the physico-chem ical properties of the toxic principles. 
These physical properties will include the effect of tem perature 
(both freezing and heating), pH stability and its effect on weight 
loss, serum protein concentration and PChE (Pseudocholinesterase) 
activity. SlnceSesbania drummondii is a leguminous plant and 
several lectins have been isolated from this family of plants, studies 
to detect the presence of a lectin and the interaction of sesbania 
extracts with a lectin (Concanavalin-A) as well as its interaction 
with reactive carbohydrates (Sephadex™ G-25) will be examined. 
The toxic compounds will be separated using hollow fiber filtration 
and the determ ination of m olecular w e ight w ill be done by 
u ltra filtra tion. The partition of toxic signs including weight loss, 
decreases in serum protein concentration and decreases in PChE
1
2activity should help to determine the presence of multiple toxins in 
crude sesbania extracts.
Sesbanim ide, a cytotoxic compound, has been previously 
isolated from the seeds of Sesbania drum m ondii (Powell et al. 
1983,1984). It possesses a structural s im ilarity to the glutaride 
c lass of an tib io tics  which are exem plified  by cyclohexim ide. 
Cyclohexim ide produces its toxicity by inhibiting the synthesis of 
proteins. Com parision studies to test the s im ila rities between 
cyclohexim ide and sesbania intoxication will be undertaken. These 
studies w ill be extended to include a h isto log ic and electron 
microscopic evaluation of the effects of sesbania and cycloheximide 
in the liver in an effort to determine sim ilarities in mechanism of 
action.
Flory and Hebert (1984) first reported that sesbania treatment 
dram atica lly  depressed the concentration of c ircu la ting  serum 
proteins in chickens. Based on the knowledge that most serum 
proteins are export protein products from the liver, it is further 
postulated that the liver represents a major target for sesbania 
intoxication, it will be important to determine whether the decrease 
in serum protein concentration is the result of the inhibition of 
protein synthesis or whether this decrease reflects an inability to 
release serum proteins (export proteins) from the liver after they 
are synthesized. This problem will be addressed by comparing the 
activities of selected marker enzymes in both the serum and liver 
fractions from control and sesbania treated rats and chickens.
Since the liver is postulated to be a site of sesbania action, the 
effects of sesbania on this organ will be assessed in different liver
3fractions. The liver w ill be fractionated into m icrosomal and
cytosolic portions by d iffe rentia l centrifugation. A select cross­
representative group of enzyme activites will then be determined to 
attempt to evaluate the mechanism of action of sesbania toxins in 
this organ.
The work w ill lead to a be tte r understand ing of the 
mechanisms of sesbania-induced toxicity. The work is fundamental 
to the future development of therapeutic intervention in accidental 
sesbania intoxication. No specific treatments are currently available 
for the management of sesbania intoxication.
REVIEW OF LITERATURE
In tro d u c tio n :
Sesbania drummondii is a small perennial toxic shrub or tree 
that grows to an average height of 1.8 to 2.7 meters. It is commonly 
found throughout the Southeastern United States, from Florida to 
Texas. Its normal habitats are wet, marshy soils and sandy loams 
where it becomes well-established. O ther habitats include low 
wooded areas, the edges of bayous, marshland, road sides, railroad 
embankments, the edges of ponds, ditches, prairies and sandy 
beaches (Lasseigne, 1973 and Marshall et a l. 1985).
The lite rature is inconsistent with respect to the correct 
botan ical c lass ifica tion  of this plant. It has been variously 
identified and reported as Sesbania drum m ondii, Daubentonia  
drummondii, Daubentonia longifolia and Sesbania cavanellesii. It 
possesses a considerab le  taxonom ic s im ila rity  to Glottid ium  
vesicarium (Broughton and Hardy, 1939; Correll and Johnson, 1970; 
Duncan et a l. 1955; Emmel, 1935 and Emmel, 1944). Several trivial 
names for this plant have come into common usage including coffee 
bean (Marsh, 1920), bagpod (Emmel, 1944 and Robey, 1925), coffee 
senna (Featherly et al. 1943) and bladderpod (Newberne, 1953).
The leaves of Sesbania drummondii are alternate and pinnate 
with several leaflets (usually 12-20). Yellow flowers, which are 
frequently tinged with purple, are present in axial racemes. The 
fru it of the plant is many-seeded, linear and compressed into a 
bladder-shaped pod. The shape of the fruit is the source of one of
4
5its trivial names, bladderpod. Some 30 species of the genus are 
recognized in tropical and subtropical regions (Lasseigne, 1973), but 
not all species are poisonous (Kingsbury, 1964). The genus name is 
derived from one of the species said to be sesban .  The seeds of 
Sesbania drummondii are toxic to all species of livestock, domestic 
fowl and humans (Ellis, I975).
H abitat and Identifica tion :
Sesbania drum m ondii was first introduced into Florida from 
the West Indies as an ornamental (Lasseigne, 1973). Sesbania 
drummondii became rapidly established and soon spread westward 
into Texas and northward into the Carolinas. By 1941, it was 
detected as far northwest as central Oklahoma (Lasseigne, 1973). 
This rapid expansion increased the potential for livestock poisoning. 
As late as 1973, Sesbania drummondii was confined to the southern 
half of the state of Louisiana (Lasseigne, 1973). This distribution 
corresponded to the coastal wetlands and coastal plains. Today, it 
can be readily isolated from most areas of the state including the 
alluvial plains which were devoid of Sesbania drummondii at the 
time of the 1973 study.
The mature pods remain on the plant long after most of the 
surrounding foliage has died from frost. In areas where food is 
scarce or where livestock are left to forage on their own, sesbania 
may be the only abundantly available plant during winter (Duncan et 
al. 1955). In addition, cattle, in particular, may develop an appetite 
for sesbania. This attraction to sesbania plants may persist long 
after hay or grass is offered (Emmel, I944).
6Most of the toxicity of the plant is associated with the mature 
pods (containing the seeds, Terblanche et a l. 1966). The fresh 
leaves are much less toxic and the pods (minus the seeds) display 
little if any toxic activity (Marsh, 1920; Marsh and Clawson, 1920; 
Simpson and West, 1953 and Terblanche et a l. 1966). Although 
cattle are now the most frequently afflicted species, sesbania 
toxicity was originally observed in a herd of goats (Marsh, 1920).
C la s s if ic a t io n :
There is litt le  taxo no m ic  ev ide nce  to suppo rt the 
classification of Sesbania, Daubentonia and Glottidium  as separate 
genera in the legume family. Their classificaition should be as a 
species of Sesbania (Lasseigne, 1973). Despite morphological pod 
and bloom differences, chromosome numbers and pairing appear to be 
identical in all these genera (Kingsbury, 1964). The Daubentonia 
d ru m m o n d i i  of Rydb, Daubentonia longifolia  of Cocks and the 
Sesbania d rum m ond ii of Turner are considered to be a single 
distinct species (Lasseigne, 1973). For the purposes of this study, 
the classification put forth by Kingsbury (1964) has been adopted. 
The complete classification is shown in Table 1.
A related plant, Sesbania punicea, a native of South America, 
is establish ing itse lf w ith in the same d is tribu tion  area as the 
Sesbania drummondii species (Lasseigne, 1973). This research has 
dealt with the effects of the d r u m m o n d i i  species and not the 
closely related p u n ic e a .  The former species has yellow blooms 
while those of pun icea  are orange-red. Nevertheless, both species 
appear to produce identical clincial signs and it would be difficult
7TABLE 1
Classification of Sesbania drummondii according to Kingsbury 
(1964).
Kingdom: Plantae
Phylum: Spermatophyta
Class: Angiospermae
Subclass: Dicotyledonae
Order: Rosales
Family: Leguminosae
Genus: Sesbania (Daubentonia)
Species: drummondii
to d iffe ren tia te  between the two species during an episode of 
poisoning (Correl and Johnson, 1970).
P ath o ph ys io log y:
Many animal species appear to be susceptible to the actions of 
sesban ia  (Terb lanche et a l. 1966). The effects of S. p u n ice a  are 
included because the pathophysiology of the two species appears 
identical. Their botanical s im ilarity strongly suggests that both 
species should contain the same or similar toxins. A potential toxin, 
sesbanim ide, has been independently isolated from both species 
(G o rs t-A llm a n  et a l. 1983 and Powell, 1983; Powell et a l. 1983). It 
has been postulated that this may be the major toxin in this genera 
(Powell, personal communicaiton).
Instances of range poisoning by these plants have been 
recognized since the latter part of the 19th century. The first 
thorough investigation of an intoxication by Sesbania drum m ondii 
was undertaken by Marsh and Clawson (1920). The incident involved 
the poisoning of sheep which had been travelling to a fresh pasture 
in Texas. The plant was abundant along the road sides and there was 
evidence of foraging by the herd which resulted in substantial 
livestock losses.
Sheep poisoned by sesbania d isp lay an assortm ent of 
pathological signs. The in itia l signs were a general restlessness 
and depression. This was followed by kyphosis, anorexia and 
diarrhea. Prior to death, the animals had shallow, rapid breathing, a 
weak and rapid pulse and became com atose. Post-mortem 
examination revealed the presence of tarry blood and / or multiple
9petechial hemorrhages of the gastro in testina l tract. H istological 
examinations showed the presence of degenerative changes in the 
gastric and mesenteric lymph nodes. A severe gastric enterititis 
was observed c lin ica lly. In sheep, th is gastric en teritis  was 
confined to an area posterior to the rumen (Broughton and Hardy, 
1939).
Severa l experim enta l in tox ica tions of ca ttle  have been 
produced with sesbania (Emmel, 1935;; Featherly et a l. 1943; 
Newberne, 1953; Simpson and West, 1953). Cattle dosed at 2% of 
body weight exhibited signs within the first 24 hours and death 
within 48 hours after a single dose. With chronic low doses, death 
occurred after 2 weeks at a daily dose of 0.15% of body weight. The 
toxic e ffects of sesbania poisoning appeared to be cumulative 
(Broughton and Hardy, 1939; Emmel, 1935; Emmel, 1944 and Shealy 
and Thomas, 1928). Poisoned ca ttle  occasiona lly  d isplayed 
constipation but their usual response is sim ilar to other species (i.e. 
diarrhea). Consumption of the seeds of Sesbania drummondii or 
other closely related species produced hemorrahagic diarrhea. Post­
mortem examination showed severe hemorrahagic inflammation of 
the sm all in testine and abomasum. G enera lized album inous 
degeneration of the kidneys and liver degeneration was noted 
h is to log ica lly  by Featherly et al (1943). This was frequently 
accompanied by limited necrosis of the liver and complete rumen 
stasis. The rumen very often contained sprouted seeds. Changes in 
the lymphatic system and smo...h musculature were also noted in 
poisoned cattle. The presence of small thrombi of degenerated red 
blood cells, throughout the circulatory system, were also reported
10
(Marsh, 1929 and Shealy and Thomas, 1928). Small quantities of the 
seeds produced diarrhea and tachycardia in cattle, sheep and goats 
(Emmel, 1944). Clinical biochemical analyses showed an increase in 
blood urea nitrogen (BUN), creatinine, glucose, serum glutamate 
pyruvate transam inase (SGPT) and serum glutamate oxaloacetate 
transaminase (SGOT) in these animals. Necropsy findings in cattle 
were sim ilar to those observed in sheep (Terblanche et al. 1966). 
As with many toxicoses, the severity of the observed signs was 
dose-related (Marsh, 1920).
Poisoning of fowl by sesbania has been predom inantly 
experimental. Duncan et al (1955) fed seeds of the closely related 
Glottidium vesicarium  (Sesbania vesicarium ) to domestic fowl at 
rates ranging from 1.13 to 2.00% of the body weight. This range was 
found to be lethal. Signs of in toxication were d iarrhea and 
prostration. Post -mortem examination showed the presence of dark 
tarry blood and a dark congested comb in the males. Necrotic 
enteritis, severe inflam m ation and necrosis of the gizzard were 
found (Duncan et a l. 1955). Duncan also reported fatty degeneration 
of the liver and edema of most of the parenchymal organs of the 
body. Signs first appeared 8 to 30 hours post exposure and were 
s im ilar to those described for poisoned sheep. In a sim ilar 
experiment with Sesbania drummondii , Duncan et al (1955) found 
evidence for acute toxicity in dosed fowl. All birds exhibited signs 
of depression. At higher doses, this depression was accompanied by 
decreased respiratory rates and lowered body temperatures. These 
symptoms were followed by the production of a mucoid diarrhea, 
dypsnea, anorexia, and a general muscular weakness. The birds were
11
prostrate until death, which was im m ediately preceded by mild 
convulsions, muscular tremors and vocalizations. Severe enteritis, 
hepatic changes and generalized congestion in other organs of the 
body were seen upon post-mortem examination. A chronic lethal 
dose was calculated to be less than 0.63% of body weight. Shealy 
and Thomas (1928) presented a more complete description of the 
toxic effects of sesbania in the domestic chicken. These included 
the observation of ruffled feathers, staggered ga it and drooped 
wings. Many whole seeds passed through the gastrointestinal tract 
w ithout being digested and could be recovered intact. Recovered 
seeds were equally toxic when fed to a fresh group of fowl. The 
comb of treated individuals was discolored and flaccid. Profuse 
diarrhea was a consistent finding and muscle tw itching in different 
parts of the body was also noted. Dramatic weight loss in affected 
individuals was paralle lled by extreme weakness. Post mortem 
examination showed severe inflammation of the proventriculus and 
ulceration of the lining of the gizzard. This ulceration led to a 
separation of the lining from its muscular layer. The intestinal 
tract was found to be inflamed and congested (Shealy and Thomas, 
1928). Chickens have been shown to be good models for studying 
sesbania-induced toxicosis. They are sensitive to the toxins and 
large numbers of birds are readily available at defined ages for 
experimentation (Flory and Hebert, 1984).
The closely related Sesbania punicea  was found to cause 
sim ilar signs in chickens (Terblanche et a l. 1966). In this case, 
hyperemia and hemorrhage of the proventriculus were characteristic 
of intoxicaiton. Petechial hemorrhages were evident in the gizzard.
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Congestion and cloudy swelling were seen in the kidneys and liver 
along with marked congestion of the lungs.
P igeons, turkeys and ducks were s im ila rly  a ffected by 
Sesbania punicea (Terblanche et a l. 1966). Pigeons vomited and 
showed hyperemia of the proximal portion of the small intestine. 
Upon histo logical examination , advanced cloudy swelling in the 
kidneys and liver was observed in treated pigeons.
In rats, an acute lethal dose of S e sban ia  p u n ice a  was 
calculated to be 3.0 g / kg (i.e. producing death within 24 hours). 
The eyelids became inflamed with hyperemia and exudation from the 
conjunctiva. Necropsy findings were sim ilar to those for other 
species, inc lud ing m ild to m oderate congestion , pu lm onary 
emphysema and hyperemia of the gut. Only posterior paralysis was 
observed in acute in to x ica tio n . Subacute s igns included 
listlessness, anorexia and diarrhea. In many cases, lesions of the 
gastrointestinal tract were not present (Terblanche et a l. 1966).
The rabbit was shown to be sensitive to fresh flowers, dried 
flowers and the seeds of Sesbania punicea. Chronic exposure 
produced marked hyperemia around the edges of the eyelids 2 to 9 
days post treatment (Terblanche et a l. 1966).
In an experiment using only a single horse, Terblanche et al 
(1966) showed a slight drop in hemoglobin concentration without a 
concom itant decrease in the hematocrit number. There was an 
increase in the amount of unconjugated bilirubin as well as a slight 
rise in the BUN. No changes in serum glutamate oxaloacetate 
transam inase, serum pyruvate oxaloacetate transam inase, serum 
alkaline phosphatase or total plasma protein were observed. The
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liver was swollen and spotted with petechial hemorrhages along the 
coronary vessels and the spleen was markedly congested. This is in 
marked contrast to the results reported by Flory and Hebert (1984) 
in chickens. The la tter had observed a severe drop in the 
concentration of serum proteins.
Pigs dosed with Sesbania punicea  showed signs of anorexia 
and gastric hemorrhages. Dogs were less susceptible than other 
animal species to intoxication since ingestion was fo llowed by 
vomiting (Terblanche et a l. 1966). Marsh and Clawson (1920) had 
previously shown that guinea pigs were susceptible to the actions of 
Sesbania drummondii. . At least one human fatality occurred in a 
small boy who drank an infusion made from the seeds of S esban ia  
dru m m on d ii (Ellis, 1975).
Studies on isolated chick intestinal and lung parenchymal 
tissue have been carried out to further elucidate the mechanisms of 
action of the toxic principles of Sesbania d rum m ondii on smooth 
muscle (Venugopalan et a l. 1984). These authors suggested that 
part of the toxic action of the plant may be mediated via inhibition 
of smooth muscle function. This inihibition was found to be most 
pronounced in isolated lung parenchymal strips.
C h e m is try :
Several com pounds have been iso lated from S e s b a n i a  
d ru m m o n d ii  , but at this time only one has been shown to be toxic 
(Powell et a l.. 1984). Robey (1925) attempted to identify the major 
toxin of Sesbania drummondii . Many of the symptoms of sesbania 
poisoning are sim ilar to those observed in in toxica tions with
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a lka lo id -like  compounds. Although Robey was unsuccessful in 
isolating alkaloids, or alkaloid-like compounds, he did detect the 
presence of a compound with the same empirical structure as a 
neutral saponin. He also had evidence for the presence of several 
acid ic saponins. However, such com pounds are not normally 
considered to be toxic. Saponins are extremely irritating substances 
known to produce hemolysis of red blood cells. Several signs of 
sesbania intoxication are consistent with the effects caused by a 
saponotoxin. These signs include severe gastric enteritis (all 
species), vomiting (in dogs), anorexia, abdominal pain and diarrhea 
(T e rb lanche  et a l. 1966). Emmel (1944) suggested that the 
absorption of a saponotoxin from prolonged retention of the seeds in 
the gastrointestinal tract m ight be responsible for the increased 
hemolysis observed. The isolation of a saponin from Sesbania 
d r u m m o n d i i  is interesting in light of the observation that in the 
horse (Terb lanche  et a l. 1966), rat and chicken (personal 
observation) there was hemolysis fo llow ing sesbania treatment. 
However, other clinical find ings of sesbania intoxication do not 
support the hypothesis that a saponin is the sole toxin. The decrease 
in serum proteins (Flory and Hebert, 1984), changes in smooth 
muscle function (Venugopalan et a l. 1984) and neurological signs 
(Shealy and Thomas, 1928) cannot be explained by the presence of a 
saponin as the major toxin in sesbania. The presence of a 
cyanogenic glucoside has been reported, but this has never been 
substantiated (Broughton and Hardy, 1939; Simpson and West, 1953).
Interest in this plant was again stimulated during the early 
1980's as part of an investigation to isolate naturally occurring
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antineop lastic  agents of botanical orig in (Powell et a l. 1983). 
Subsequent research led to the isolation of three major compounds. 
Two of these are the alkaloid sesbanine and the alcohol drummondol 
(Figure 1). A third compound, sesbanim ide, isolated in minute 
quantities was shown to have antineoplastic activity. The structure 
of this antineoplastic compound is shown in Figure 1. Sesbanimide 
has been reported to be similar in structure to the glutaride class of 
antibiotics, such as cycloheximide (Powell et a l. 1984). Due to this 
sim ilarity in structure and to the extrem ely small yield of this 
compound (2 g from 450 kg of seeds), the suggestion has been made 
that sesbanim ide might be from a microbial source contaminating 
the seed m ateria l (G orst-A llm an et a l. 1983). However, 
sesbanim ide has been independently isolated from the closely 
related Sesbania punicea  and its structure confirmed by Gorst- 
Allman et al (1983) using NMR spectroscopy. Studies on the 
pathophysiology of sesbanimide in animals have not been published. 
It is unlikely that sesbanim ide is the sole toxin of S e s b a n i a  
drummondii.
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Figure 1: Structures according to Powell gLal, 1979; Powell et al. 1984.
MATERIALS AND METHODS
Source of Toxic Material:
Seed pods were collected from various areas in Louisiana. 
Initially, the seeds were removed from the pods with forceps and 
the collected seeds ground in a 2 mm screen meshed Wiley mill. 
However, it was found that the ground seeds and pods had virtually 
the same toxicity as whole ground seeds. Therefore, ground seeds 
and pods were used for the remainder of the experiments except as 
indicated. The ground materials were kept in an air-tight amber 
glass container until needed.
Preparation of Extracts:
The whole extract was prepared by suspending ground seeds 
and pods (henceforth referred to simply as ground seeds) in 0.025M 
sodium bicarbonate, 0.2% sodium azide buffer (BBN buffer, pH 7.0) 
in a ratio of 1 part ground seeds to 5 parts of buffer. The seeds 
were soaked overnight at 4C and the extract recovered by vacuum 
filtration through 6 layers of cheesecloth. Concentration of the 
extract was reported as the volume of filtrate per gram of seeds. 
This was the crude extract was used for dosing of animals by 
gavage.
A 20K (46,000 x g supernatant) fraction was prepared in the 
following manner : ground seeds of Sesbania drum m ondii were
suspended in BBN buffer in the ratio of 1 part seeds to 5 parts 
buffer and processed in a Waring blender for 9 minutes at the
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highest speed with in term ittent cooling of the vessel in an ice- 
water bath. The homogenate was centrifuged at 46,000 x g 
(20,000 r.p.m.) for 20 minutes at 4C in a Beckman J21B preparative 
centrifuge using a JA-20 rotor. The supernatant fraction was 
decanted through 6 layers of cheesecloth and the volume recorded. 
The concentration of th is extract was expressed as the ml of 
extract recovered per gram of seeds.
pH Stability and Fractionation:
A 20K fraction was adjusted to the desired pH (2, 4, 6, 8, 10 
or 12) with either 11.6 N HCL or 30.0 N NaOH to minimize volume 
changes. Precipitate formed was removed by centrifugation at 
46,000 x g for 20 minutes. Both supernatant and pellet fractions 
were recovered. The supernatants were adjusted to pH 7.0 and the 
precip itates were resuspended to the ir original starting volumes 
with BBN buffer (pH 7.0) prior to dosing.
D ia ly s is :
W hole extract or 20K fraction was dialyzed against 200 
volumes of BBN buffer (pH 7.0) in dialysis tubing with a molecular 
weight cutoff of 20,000 (Union Carbide, Chicago, IL). All fractions 
were dialyzed at 4C for 24 hours with three buffer changes.
Concanavalin-A Sepharose™ and Sephadex™ G-25:
Five grams of Sephadex™ G-25 (Pharmacia Fine Chemicals, 
Uppsala, Sweden) were swollen overnight in BBN buffer (pH 7.0). A 
slurry was prepared by mixing 10 ml of the 20K fraction with
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swollen Sephadex™ G-25. This slurry was stirred for 4 hours at 
room tem perature, vacuum filtered through W hatman #1 filte r 
paper and used d irec tly  to dose chickens. C oncanavalin-A
Sepharose™ (Sigma Chemical Co., St. Louis, MO) was prepared in an 
analogous manner.
Agarose:
Agarose (Sigma Chemical Co., St. Louis, MO) was swollen 
overnight in BBN buffer (10 gm / 100ml of BBN buffer, pH 7.0). The
gel was recovered by vacuum filtration through Whatman #1 filter
paper and gently mixed with 20K fraction in a 1:1 ratio with
in term ittent stirring at room tem perature for four hours. This 
mixture was filtered through Whatman #1 filter paper. The filtrate 
was used to dose animals. An equivalent volume of alpha-methyl- 
glucoside (10mg / ml) in BBN buffer (pH 7.0) was added to the 
filte red agarose gel, perm itted to mix for 4 hours at room 
temperature and filtered as described above. This filtrate was used 
to dose chickens.
Tem perature  S tab ility :
A 20K fraction was frozen overnight at -20C (slow freeze), 
thawed at room temperature and used for dosing studies. In other 
experiments, the 20K supernatant was shell-frozen (fast freeze) in 
a dry-ice / methanol bath (approximate freezing temperature -60C) 
and lyophilized under vacuum using a Virtis uni-trap model 10-100 
lyophilizer (Virtis, Gardner, NY). The residue was resuspended in a
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volume of distilled water equivalent to the original volume of the 
20K supernatant.
The 20K fraction was held at 37C, 50C or 80C for one hour. 
These extracts were cooled and used directly for dosing.
U l t r a f i l t r a t io n :
Each 20K fraction was sequentially filtered through 0.45 jam 
and 0.20 pm filters (Millipore Corp, Bedford, MA) sequentially prior 
to fractionation with a hollow fiber u ltrafiltrator. Samples were 
prefiltered to avoid clogging the hollow filber membranes with 
particulate material. The initial fractionation used a hollow fiber 
apparatus (Amicon CH4, Danvers, MA) with a molecular sieve limit 
of 1000. The <1000 MW filtrate was further separated at 4C into 
<500 and >500 MW fractions using a nitrogen driven (379.2 kp) 
Amicon ultafiltration cell fitted with a YC 0.05 membrane (Amicon 
Corp., Danvers, MA). The >1000 and <1000 MW fractions were 
brought back to their original starting volumes with BBN buffer 
prior to dosing. The effective molecular weight cutoff of the YC 
0.05 filte r was 350 MW. The fina l protocol for the partial 
purification is shown in Figure 2.
C ycloh ex im ide :
Cycloheximide, a glutaride antibiotic (Sigma Chemical Co., St. 
Louis, MO) was used to dose randomly selected mixed-sex, adult 
Sprague-Dawley rats. Animals were dosed with either 0.18 or 
0.54 mg / kg per day for three days. A control group and a group
21
pellet 
(discard) *
200 gm seeds 
in BBN buffer 
46,000 x g 
(20minutes)
pellet 
(discard)
pellet 
(discard)
filtrate - 
hollow fiber 
(1000 MW cutoff)
I
>1000 MW 
(used to dose) 
used to dose
500-1000
(discard)
residue
(discard)
supernatant 
46,000 x g 
(20 minutes)
supernatant 
46,000 x g 
supernatant
filtered 
(Millipore 0.45pm) 
filtered 
(Millipore 0.20pm)d
supernatant 
adjusted to pH 10
adjusted to pH7 
(used to dose)
pH 2 supernatant
46,000 x g 
(20 minutes)
split 1/2 and 1/2
split 1/2 and 1/2 — — 
(500 MW cutoff)
500 MW 
adjusted to pH 2
46,000 x g 
(20 minutes)
<1000 MW
<1000 MWultrafiltered
pellet
(discard)
pellet
(discard)
aqueous fraction 
(discard)
extracted with ethyl acetate 
( 1 :1)
ethyl acetate fraction 
air dry over CaCl2 
resuspended in BBN 
(used to dose)
Figure 2: Protocol for the preparation of the <500 MW, ethyl
acetate extractable toxin from Sesbania drummondii.
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receiving 0.3% body w eight of a 20K supernatant fraction of 
Sesbania drummondii for three days were included.
Attempted Isolation of Sesbanimide:
A <500 MW fraction was adjusted to pH 2 with 11.6 N HCI and 
the precipitate separated by centrifugation at 46,000 x g  for 20 
minutes. The supernatant fraction was recovered and adjusted to 
pH 10 with 30N NaOH. After 30 minutes, precipitate formed was 
removed by a second centrifugation step at 46,000 x g  for 20 
minutes. The superantant fraction was decanted and extracted 
three times with equal volumes of ethyl acetate in a separatory 
funnel. The ethyl acetate layers were removed and air-dried over 
C a C l2 - The dried extract was adjusted to the original starting
volume with BBN buffer (pH 7.0) and used for dosing.
In a separate experiment, the 20K fraction was adjusted to pH 
10 and extracted  d irec tly  into e thyl acetate w ithou t prior 
purification and the resulting extract treated as above. Three 
layers resulted from this fractionation: aqueous, ethyl acetate and 
in te rm ed ia te  ethyl ace ta te -w a te r. The ethyl ace ta te -w ater 
emulsion, which could not be separated by the addition of 1M NaCI, 
was removed intact and centrifuged at 46,000 x g  for 20 minutes. 
Centrifugation did not separate the emulsion. This emulsion was 
air dried over a bed of CaCl2 -
Since the ethyl acetate fraction was found to be lethal, 
further purifica tion aimed at the isolated of sesbanim ide was 
attempted from the <500 MW fraction. As described above, the pH 
10 adjusted <500 MW fraction was extracted into ethyl acetate and
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taken to dryness. The residue was suspended in an equivalent 
volum e of hot m ethanol (60C) w ith  rapid s tirring . Cold 
dichloromethane (4C) was added to this methanol suspension. As no 
precip itate was formed, the entire organic phase was taken to 
dryness and the residue prepared for dosing with the addition of 
BBN buffer. A flow diagram of this procedure is outlined in Figure 
3.
Thin Layer Chromatography:
Thin layer chromatography was developed with a mobile phase 
of ch lo ro fo rm , m ethanol, and ace tic  acid (60:35:5) on 
fluo rescence-suppressed s ilica  gel plates (W hatman UV 256, 
Springhill, England). Samples of <500 MW and pure sesbanimide (a 
gift from Dr. Richard Powell, USDA Labs, Peoria IL) were spotted 
onto the plates in 5 jil aliquots using a 10 pi gas-tight syringe 
(Allometrics, Baton Rouge, LA). The developed TLC plates were 
visualized using the following colorim etric reagents.
Dragendorff solution: Solution A consisted of 2 gm of bismuth
subnitrate in 25 ml glacial acetic acid diluted to 100 ml with 
d is tilled  deionized water. Solution B consisted of 40 gm of 
potassium  iodide made up to 100 ml w ith d is tilled  water. 
Dragendorffs reagent consisted of 10 ml of solution A and 10 ml of 
soution B plus 20 ml of glacial acetic acid q.s. to 100 ml with 
distilled water. The final solution was orange-colored.
Mandelin reagent: 0.5 gm of ammonium vanadate was
dissolved in 100 ml of concentrated sulfuric acid. Slight warming 
was necessary to completely dissolve the salt.
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Figure 3: isolation scheme tor sesbanimide from partially purified
extracts of Sesbania drummondii.
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lodo-platinate reagent: lodo-platinate (Whatman Chemical Co, 
S p ringh ill, England) was prepared as a 0.15%  potassium  
chloroplatinate, 3% potassium iodide spray reagent.
Potassium permanganate: 40 gm of potassium permanganate
was dissolved in methanol and made up to 2000 ml with distilled 
w a te r.
Concentrated sulfuric acid: 36 N was sprayed onto a plate and 
gen tly  charred  over a bunsen bu rne r to v isu a lize  the 
chromatographed compounds.
UV: A hand held long and short wave variable ultraviolet light 
was used to detect fluoresecent compounds in the mixture.
A n im a ls :
Dom estic W hite Leghorn ch icks were hatched at the 
Department of Veterinary Science of Louisiana State University. 
Day old chicks were kept in heated brooders and fed Purina chick 
"Startena" and water ad libitum. No change in diet was effected 
throughout the experimentation. Heat was no longer necessary in 
the brooders after one week of age. Rhode Island Red chickens 
were occasionally used for experimentation. No breed differences 
were observed. Chickens were usually 2.5 to 3 weeks of age at the 
start of the experiment. Young chick groups (immature) were 
chosen to be less than 14 days old, while 6-9 week old chickens 
were placed in mature chicken groups. Six day old chicks were 
used for studies with pure sesbanimide. For each experiment, all 
chickens were of the same age (hatched on the same day) and were 
randomly divided into experimental groups.
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All rats used in these studies were Sprague-Dawley males 
(except for BNF developm ental studies which were prepubertal 
females) and were fed Purina rat chow and water ad libitum . Young 
rats were weaned at 19 days and used for experimentation from 
days 22 to 33 (prepubertal rats) . Rats were randomly assigned to 
treatment groups. Adult male rats were used in the majority of 
experiments and were handled in the same manner as were young 
anim als.
W eight calculations were reported as the percentage of the 
initial weight on any given day as described below.
[ (Wx-Wi) / Wi ] x 100
where Wx referred to the weight of the animals on any given day (X) 
and W i was the initial weight of that animal at the start of the 
experim ent.
Determination of Serum Parameters:
Serum bilirub in  concentra tions were quantita ted using a 
commercial kit (Sigma Cheimcal Co., St. Louis, MO).
Immunodiffusion experiments were carried out as described by 
Fahey and McKelvey (1965). The agar buffer consisted of 300 mM
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potassium phosphate buffer (pH 8.0) containing 1 M NaCI and 5.95 
mM EDTA (disodium ethylene diamine tetraacetate); 15 gm of Noble 
agar (Difco, Detroit, Ml) was added to 1 liter of buffer and heated
until dissolved. The solution was cooled to 70C and merthiolate
(1:1000 w / v) was added as a preservative. The agar preparation 
was stored at 4C in 10 ml aliquots for future use. Prior to use, the 
agar was melted at 95C in a water bath. Antiserum (a dessicated 
sample of 2 ml of antiserum) was dissolved in 5 ml of agar buffer
and warmed for 2 minutes at 56C. The antisera (5ml) and heated
agar (5ml) were qu ickly mixed and poured onto a calibrated 
im m unodiffusion plate. The m ixture was perm itted to harden 
overnight at room temperature. Wells (3mm) were cut into the agar 
using a commerical template and filled with either standard serum 
samples for calibration or with test samples. Plates were incubated 
in a hum idified chamber at room tem perature for 24 hours and 
antibody-antigen precip ita ting diam eters recorded. A standard 
curve was plotted on semi-log paper as the concentration of protein 
versus ring diameter after 24 hours.
Serum electrophoresis (Davis, 1964) was carried out using 
standardized cellulose acetate backed plates (Helena Laboratories, 
Beaumont, TX). Plates were electrophoresed for 20 minutes at 100 
volts. Proteins were stained according to kit instructions with 
Ponceau S dye for 10 minutes and destained in 5% acetic acid. 
P ro te in  in te n s ity  was q u a n tita te d  w ith  a tra n s m itta n c e  
densitometer following plate clearing in 30% ethyl acetate and 70% 
glacial acetic acid (Helena Laboratories, Beaumont, TX).
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Liver Fractionation:
Livers were removed from experimental animals immediately 
following decapitation, rinsed once in ice cold 50 mM Tris, 1.15% 
KCI (pH 7.4) and patted dry for weighing. Following weighing, the 
livers were placed in ice-cold buffer, minced with scissors, rinsed 
once with fresh buffer and resuspended in fresh ice-cold buffer (pH 
7.4) in a volume equivalent to twice the weight of the livers. They 
were hom ogenized using a SDT-1810 T issuem ize r (Tekm ar, 
Cinncinati, OH) at a speed setting of 1/2 for 30 seconds. The 
homogenate was centrifuged at 7,800 x g for 20 minutes to remove 
red blood cells, cellular debris and mitochondria. The supernatants 
were decanted and recentrifuged at 102,000 x g  for one hour in a 
Dupont-Sorval ultracentrifuge Model OTD-65 equipped with a Ti 865 
fixed angle rotor. All the preceeding steps were done at 4C. The 
cytosolic supernatant was decanted and its volume recorded. The 
microsomal pellet was carefully resuspended in ice-cold 1.15% KCL 
contain ing 10 mM EDTA. M icrosomes were recovered after 
centrifugation at 102,000 x g  for one hour. The microsomes were 
resusupended in the ice-cold KCI-EDTA buffer in a volume equivalent 
to the volume of the original cytosolic fraction. These microsomal 
fractions were used immediately for the spectral quantitation of 
cytochrome P-450 according to the method of Guengerich (1982).
Sulfhydryl Group Availability:
Sulfhydryl group ava ilab ility  (SH) was quantita ted in the 
following manner. A standard curve was constructed using various 
glutathione concentrations. Each cuvette contained 1.45 ml of 0.5
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mM dithiobisnitrobenzoic acid, 1.50 ml of distilled water and 50 pi 
of a known concentration of glutathione. The reaction was allowed 
to proceed for 5 minutes after which the absorbance was measured 
at 405 nm. The absorbance versus glutathione concentration was 
then plotted as a standard curve. Samples were reacted in a similar 
manner and the ir su lfhydry l a va ilab ility  de term ined from  the 
glutathione standard curve.
Enzyme Activity Assays:
Lactic dehydrogenase (LDH) was assayed by the method of 
Reeves and Fimognari (1966) with the following modifications. The 
buffer used in the assay was 0.05 M potassium phosphate (pH 7.4) 
containing 1% BSA and 0.15 M NaCI. Substrates were sodium 
pyruvate (0.226 M)) and NADH (7.5 mM). A general stock solution 
consisted of the following: 3.0 ml of a 1% solution of BSA, 3.0 ml of 
phosphate buffer, 0.2 ml of pyruvate solution, 1.42 ml of NADH 
solution and 15.3 ml of distilled water. To each 3.0 ml cuvette, 1.45 
ml of general stock solution and 1.35 ml of distilled water were 
added. The reaction was initiated by the addition of 50 pi of the 
enzyme preparation. The total assay volume was 3.0 ml. The 
reaction was assayed at 340 nm against a reagent blank in a Bausch 
and Lomb 2000 spectrophotom eter at room tem perature. The 
sources of enzyme were serum, liver cytosol or liver microsomes. 
Enzyme activity was calculated from the disappearance of NADH 
using an extinction coefficient of 6.22 x 106 liters / mole-cm.
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Pyruvate kinase was assayed according to the method of Flory 
and Koeppe (1973). A 50 mM potassium phosphate buffer was 
adjusted to pH 7.5 by the addition of 1M NaOH and the concentration 
of potassium in this buffer was made to 90 mM with the addition of 
40 mM KCL. The buffer also contained 1 mM 2-mercaptoethanol. The 
reaction mixture consisted of 0.145 mM NADH, 5 mM MgSC>4 , 0.6 mM
phosphoenolpyruvate (PEP), 1.5 mM adenosine diphosphate (ADP) and 
lactate dehydrogenase (final concentration, 50 units / ml) from 
rabbit muscle (Sigma Chemical Co., St. Louis, MO). Total volume of 
the assay was 3.0 ml and the reaction was initiated by the addition 
of 50 pi of test serum. The reaction cuvette was assayed against a 
reagent blank containing everything but serum. The samples were 
assayed in the presence and absence of fructose 1,6 (bis) phosphate 
(FBP, 1 mM). A total of 10 pi of the FBP was added to the assay 
cuvette. All reactions were carried out at room temperature for one 
minute and assayed at 340 nm. Enzymatic activity was measured as 
the disappearance of NADH using an extinction coefficient of 6.22 x 
10® liters / mole-cm.
G lucose 6-phosphate dehydrogenase (GPDH) was assayed 
according to the method of Langdon (1966). The reagents used were 
: 1 M Tris-chloride buffer (pH 7.5), 0.025 M glucose 6-phosphate,
0.002 M NADPH and 0.2 M MgCl2 . A 0.1 ml aliquot of each reagent
was added to 2.55 ml of distilled water and 50 pi of enzyme added 
to initiate the reaction. The final volume of the assay mixture was 
3 ml. The reaction rate was monitored at 340 nm for 1 minute in a 
Bausch and Lomb 2000 spectrophotom eter at room temperature. 
Units of enzyme activity were defined as the quantity of enzyme
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that catalyzed the reduction of 1 pmole of NADP / minute using an 
extinction coeficient of 6.22 x 10® liters / mole-cm.
G lutathione peroxidase was quantita ted by the method of 
Wendel (1981). Assay cuvettes contained 100 pi of potassium 
phosphate buffer (0.25 M, pH 7.0) containing 2.5 mM Na2 EDTA, 2.5 
mM NaN3 , 100 pi yeast glutathione reductase (6 pmoles / ml, Sigma 
Chemical Co., St. Louis, MO), 100 pi of reduced glutathione (10 mM), 
100 pi of NADPH (2.5 mM) and 100 pi of enzyme solution diluted to 
a protein concentration of 0.3 mg / ml. The volume was adjusted to 
2.9 ml with distilled water. This reaction mixture was preincubated 
at 37C for 10 minutes. The reaction was initiated by the addition of 
100 pi of cumene hydroperoxide. The final volume of the reaction 
mixture was 3.0 ml. The linear increase in NADP was recorded at 
366 nm. The spontaneous rate of NADPH oxidation was assessed in 
the absence of the enzyme and subtracted from reaction rates. One 
unit of activity was defined as a change in absorbance of 0.868 / 
minute / mole of reduced glutathione (GSH). The concentration of 
GSH was taken as unity. This coupled assay did not permit the use 
of alternative substrates but was suitable for the determ ination of 
g lu tath ione peroxidase activ ity  in crude hom ogenates (Wendel, 
1981).
The g lutath ione -S-  transfersase isozymes (GSH-T) were 
d e te r ­
mined by the method of Habig et al (1974). Each cuvette contained 2 
ml of potassium phosphate buffer (0.1 M, pH 6.5) with 1 mM GSH, 40 
pi of the substra te (1 -ch lo ro ,2 ,4 -d in itrobenzene  d isso lved in 
ethanol) and 30 pi of enzyme preparation (1/100 dilution of liver
32
fractions with 0.1 M potassium phosphate buffer, pH 6.5 of liver 
fracitons). The reaction was monitored at 340 nm for 3 minutes. 
The enzym atic  ac tiv ity  was ca lcu la ted  using the extinction 
coe ffic ien t of 9.6 liters / mole-cm fo r the form ation of the 
glutathione conjugate. The following modifications were made for 
the assay of alternate substrates. The conditions of the assay for 
using 1,2 dichloro,4-nitrobenzene were 1 mM substrate, 5 mM GSH 
and 0.1 M potassium phosphate buffer (pH 7.5). The enzymatic 
activity was quantitated at 345 nm using an extinction coefficient 
of 8.5 liter / mole-cm for the glutathione adjunct. The assay of 4- 
fra n s -p h e n y l, 3 -buten-2-d ione which dem onstra tes ac tiv ity  for 
alpha, beta unsaturated ketones as substrates, was performed in the 
following manner (Ukagi et al. 1985). The assay cuvette contained 
100 pi each of 0.1 M potassium phosphate buffer (pH 6.5), 0.05 mM 
4-frans-phenyl, 3-buten-2-dione and 0.25 mM GSH. The reaction 
was in itia ted by the addition of 20 ,ul of a 1/100 dilution of
microsome or cytosol with potassium phosphate buffer. The final
volume of the reaction was q.s. to 3.0 ml with distilled water. The 
reaction rate was monitored at 290 nm for one m inute and
enzymatic activity was calculated using the extinction coeffic ient 
of -24.8 liter / mole-cm for substrate loss. The thiolipase activity 
of glutathione-S- transferase was measured by the method of Lankin 
et al (1984). Each cuvette contained 1 ml of 0.3 M potassium
phosphate buffer (pH 7.0), 50 pi of 0.03 mM GSH, 50 pi of 12 mM 
nitrophenyl acetate (substrate), 50 pi of 60 mM EDTA and 1 ml of 
distilled water. The reaction was initiated by the addition of either 
50 pi of microsomal or cytosolic preparations. The reaction was
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monitored at 405 nm for 1 minute. The extinction coefficient for 
the formation of nitrophenol was 13.6 x 10® liters / mole-cm. A 
summary of these assay conditions is found in Table 2.
Acetylcholinesterase (AChE) and pseudocholinesterase (PChE) 
were assayed according to the method of Mount and Oehme (1981). 
Each cuvette contained 1.45 ml of 0.5 mM dithiobisnitrobenzoic acid 
in 0.1 M Tris-HCI (pH 7.4), 1.35 ml of distilled water and 100 pi of 
sample. The reaction was initiated by the addition of 100 pi of the 
substrate, butyrylth iocholine iodide (0.156 M). The reaction was 
monitored spectrophotom etrically at 405 nm at room temperature 
for 1 minute. Enzymatic activity was calculated for the appearance 
of the mixed disulfide using the extinction coefficient of 45.7 x 10" 
6 liters / mole-cm. Total cholinesterase activity was assayed in an 
analogous manner, using acetylth iocholine iodide (0.156 M) as 
substrate. AChE a c tiv itie s  were determ ined as the difference 
between acetyl and butyrylthiocholine activities.
Alkaline phosphatase (APase) was assayed according to the 
method of Bowers and McComb (1966). The assay cuvette contained 
0.8 ml of 1.0 M Tris-HCI buffer (pH 10) and 0.1 ml of 0.01 M para-  
nitrophenylphosphate. The reaction was initiated by the addition of 
100 pi of enzyme preparation and monitored at room temperature, 
spectrophotom etrically at 405 nm. Total volume of the reaction 
mixture was 1.0 ml. An extinction coefficient of 13.6 x 106 liters / 
mole-cm was used to calculate enzyme activity for the formation of 
para- nitrophenol.
Gamma glutamyl transpeptidase (GGT) was assayed using a 
commerical kit (Sigma Chemical CO., St Louis, MO). This assay
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TABLE 2
Conditions for spectrophotometric analysis of glutathione -S - 
transferase isozymes.
Substrate Cone.
(mM)
GSH
(mM)
PH lambda
(nm)
liters
Extinction 
Coefficient 
/ mole-cm
DCNB 1.00 5.00 7.5 345 8.5
DNCB 1.00 1.00 6.5 340 9.6
PBD 0.05 0.25 6.5 290 -24.7
NPA 0.20 0.50 7.0 405 13.6
DCNB = 1,2-dichloronitrobenzene 
DNCB = 1-chloro,2,4-dinitrobenzene 
PBD = 4-trans- phenyl, 3 buten-2-dione 
NPA = para - nitrophenylacetate
From: Habig, W.H. and W.B. Jacoby (1981) In: Methods in Enzymology, Academic Press, New 
York, 21, 400.
I
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quantitia tes the liberation of para- n itro a n iso le  from  gam m a 
g lu tam yl-pa ra -n itroan iso le . The para  -nitroanisole is diazotized to 
form a pink azo dye, the concentration of which is proportional to 
the GGT activity.
Protein D eterm inations;
Serum proteins were routine ly monitored by means of a 
tem pera tu re  com pensated hand-he ld  re frac tom ete r (Am erican 
O ptica l, Keene, NH). Liver cytoso lic  and m icrosom al protein 
concentrations were quantitated by the biuret method as described 
by Layne (1957). The biuret reagent was prepared by the addition of 
6 gm of Na-K tartrate, 1.5 gm CUSO4 .5 H 2 O, 30 gm of NaOH and
distilled water to a solution volume of 1 liter. Total assay volume 
was 5.0 ml consisting of 4.0 ml of assay reagent and 1.0 ml of 
protein sample. Bovine serum albumin (BSA) was used as a protein 
standard at the following concentrations 0, 1, 3, 6 and 10 mg / ml. 
Standard curves were constructed from duplicate samples and 
measured on a spectrophotom eter at 500nm. Unknown protein 
concentrations were derived from the BSA standard curve.
Histo log ica l Preparation:
Livers were rem oved from  rats im m ed ia te ly  fo llow ing 
decapitation and cut to an appropriate size with a fresh razor blade. 
The tissue was washed twice with 0.85% saline and placed in 10% 
form alin overnight.
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Specimens were trimmed to fit a 5 mm x 10 mm x 2 mm
molding cup. Samples were dehydrated tw ice in each of the
following concentrations of ethanol: 70, 80, 90 and 95%. Samples 
were maintained in each dehydrating stage for 10 minutes. Totoal 
dehydration time was one hour.
Infiltration medium consisted of 5 parts 2-butoxy ethanol in 
50 parts of hydroxy ethyl methacrylate butoxy-ethanol. Samples 
were polymerized at room temperature for two days. The specimens 
were removed from their respective molds and sectioned on a JB 4 
ultramicrotome (Sorval, Dupont CO., Wilmington, DE) at 3 microns of 
thickness. Sections were dried overnight at 60C and cooled for 15 
minutes prior to staining.
Sections were stained in G ill's hematoxylin III preparation 
(Polysciences, Warrington, PA) for 45 minutes and rinsed in tap
water (20 dips each specimen). Nucleus staining was intensified by 
placing each specimen in Scott's tap water substitute (0 . 2  gm 
N a H C 0 3 , 1 gm MgS0 4 .7 H 2 0  made up to 100 ml with water) for 25
m inutes. Specimens were rinsed 20 times in tap water and 
countersta ined with 1 % eosin Y in 70% ethanol (Polysciences,
Warrington, PA) for 25 minutes. The samples were dehydrated in 
absolute ethanol (10 dips / sample) and cleared in xylene. Cover 
slips were mounted over each specimen with Pro-Tex mounting 
media (Lerner Laboratories, New Haven CT).
Transm ission Electron M icroscopy:
Livers were immediately removed from decapitated rats and 
s liced into 1 mm blocks. Sam ples were fixed  in 1.25%
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glutaraldehyde and 2 % formaldehyde in 0 .1  M sodium cacodylate 
buffer (pH 7.4) at room temperature for one hour. The specimens 
were washed with 0.1 M sodium cacodylate buffer (pH 7.4) 
containing 5% sucrose for 10 minutes at room temperature. The 
washing procedure was repeated three times.
The specimens were stained with 2% uranyl acetate in 0.2 M 
sodium acetate buffer (pH 3.5) at room temperature for 2  hours and 
washed with deionized water 3 times for 10 minutes each.
The dehydration procedure was as follows: 30% ethanol (5 
minutes), 50% ethanol (5minutes), 70% ethanol (5 minutes x 2); 80% 
ethanol (10minutes x 2), 90% ethanol (10 minutes x 2) and 100% 
ethanol (10 minutes x 3).
Specimens were infiltrated in the follow ing manner: epoxy 
(Epon 812, Electron Microscopy Sciences, Fort Washington, PA) and 
propylene oxide in a ratio of 1:3 for 30 minutes, followed by epoxy 
and propylene oxide in a ratio of 2 :2  for 1 hour. The epoxy resin 
concentrations were increased to a 3:1 ratio and samples maintained 
in this mixture for 30 minutes. This was followed by two changes 
of Epon 812 alone for 30 minutes each. The final polymerization 
step involved the addition of 15 jul of DMP-30 (polymerization 
catalyst) to Epon 812 for 30 minutes and post-staining the samples 
with 1 % lead acetate.
Polymerization proceeded at 60C for 24 hours, after which the 
specimens were removed from their molds and the blocks trimmed 
and sectioned on a LKB 4 u ltram icrotom e (LKB Instum ents, 
Gaithersburg, MD). Sections were placed on 200 mesh copper grids
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and photographs taken with a Zeiss EM 10 transmission electron 
m icroscope.
S ta tis tic a l C a lc u la tio n s :
Ind ividual results used for s ta tis tica l analyses were the 
means of duplicate samples. Com parisons were made directly 
between control animals and Sesbania drum m ondii treated animals 
using the Student's T test. When the effects of more than two 
treatments were analyzed, an analysis of variance (ANOVA) was 
done. Since the age and sex of the animals were controlled, the 
analysis was of a one-way ANOVA. Pooled samples were treated as 
described by Steel and Torrie (1980). Comparisons involving more 
than 2  treatments were made using Tukey's w  procedure following 
analysis of variance. This test is applicable to pairwise comparison 
of means and makes use of the Studentized range.
RESULTS
Prelim inary Studies on Toxin Isolation: 
E xtract S o lu b iliza tio n :
A comparison of weight loss in 2-3 week old chickens of 
mixed sex and mature rats of mixed sex dosed with whole extract 
and a 20K supernatant is shown in Figure 4. Birds dosed by gavage 
with whole extract or 20K supernatant exhibited equivalent weight 
loss (Figure 4). However, differences were noted in the mortality 
rate. The whole extract was more toxic (100% mortality within 4 
days) than was the 20K supernatant, where 7 days of dosing were 
required for 1 0 0 % mortality (Figure 4). The majority of the toxicity 
was found in the aqueous soluble fraction. No m ortality was 
associated with the pellet fraction (Figure 4) although animals 
receiving sesbania pellet fractions failed to gain weight as rapidly 
as did control animals (Figure 4).
Rats showed sim ilar weight losses upon dosing with either 
whole extract or 20K supernatant during the first two days of 
dosing. By days 3 and 4, however, rats dosed with the 20K 
supernatant had lost significantly less weight (P<0.05) than rats 
receiving the whole extract.
Serum protein and PChE (Pseudocholinesterase) activity in 10 
day old chicks, quantitated after either 4 days of whole extract or 
20K supernatant treatment, are shown in Table 3. Serum protein 
concentrations were depressed by both whole extract and 20K
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TABLE 3
Circulating serum proteins and serum PChE in 10 day old chicks 
dosed with Sesbania drummondii extracts.
TREATMENT Protein
(mg/ml)
AWeight
(% )
PChE
(units)
Control 3.65 35.60 0.054
+-0 .0 2 +- 0.67 +- 0 .0 0 2
Whole Extract 2.72* - 25.50 0 .0 2 2 *
+-0.05 +- 0.33 +- 0.000
2 0 K Supernatant 2.31*~ - 36.70*~ 0.007*~
+-0 .0 2 +- 0.78 +- 0.000
Values are the means +- the SEM for n= 10 animals
Control animals were untreated. Treated chickens were dosed for four days at 0.5% of 
their body weight/day.
A Weight is the percentage change in body weight at day 4 from the initial predose 
weight.
PChE (Pseudocholinesterase) units are expressed as nanomoles of substrate converted 
per minute per mg of protein at 22C.
Whole extract refers to ground seeds of Sesbania drummondii suspended overnight in 
BBN buffer (pH 7.0) in a ratio of 1 part seeds to 5 parts buffer and subsequently 
filtered through cheescloth under vacuum. The resultant filtrate was used for dosing.
20K supernatant refers to the 46,000 x g (20,000 rpm) supernatant fraction of 
homogenized ground sesbania seeds.
* = means are significantly d ifferent from values obtained for control animals 
(P < 0 .05 ).
~ = means are significantly different from values obtained for whole extract treated 
animals.
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supernatant treatments. The amount of decline was significantly 
(P<0.05) greater for those animals receiving the 20K supernatant. 
S im ilarly, w e ight loss was also found to be greater in 20K 
supernatant treated birds. The reverse was seen in older birds 
(Figure 4). Serum PChE activity was decreased by both treatments. 
Quantitatively, this decline was greatest for the 20K supernatant 
treated chickens.
F as tin g :
Three week old chickens fasted over the same time frame as 
animals that had received sesbania extracts lost a substantial 
amount of body weight (32% over the first four days compared with 
37% for sesbania treated birds). However, fasted chickens retained 
normal serum protein concentrations (3.4 mg/ml compared with 3.6 
mg/ml for control animals, Table 4). The PChE activity in fasted 
chickens was unchanged compared with control birds, whereas, 
sesbania treated chickens, in a parallel experiment showed only 19% 
of the PChE activity observed for control chickens (not shown). 
Neither sesbania trea tm ent nor fasting altered serum glucose 
concentrations. Fasted chickens lacked the petechial hemorrhages 
or smooth muscle changes that were typical of sesbania poisoned 
chickens.
pH:
The effects of pH fractionation on the toxicity of the 20K 
supernatant is shown in Table 5 (rats) and Table 6  (chickens). In 
rats, weight loss (-15.1%) was highest in those animals receiving
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TABLE 4
Comparison of fasting and sesbania treatments in chickens on 
weight loss, serum protein concentration and PChE activity.
Treatment Serum Protein 
(mg/ml)
AWgt
(% )
Serum Glucose 
(mg/ml)
Control 3.6 +26.4 243.0
+-0.4 +- 9.8 +-6.3
Fasting 3.2 -32.0 * 237.0
+-0 .2 +-11.4 +-2 .2
Sesbania Extract 2.3 -37.0 * 249.0
+-0 .6 +- 8.3 +-7.9
Results are the means of values for n=6 chickens +- the SEM.
* = means are significantly different from values obtained for control values (P<0.05). 
Chickens were fasted or treated with 1% sesbania extract for 4 days.
TABLE 5
Change In w e igh t and m orta l i ty  In rats dosed w ith  pH ad justed 20K 
extracts  of Ses ban ia  drummondi i .
T re a tm e n t S a m p le AV/elaht
( % )
M o r ta l i ty
C o n tro l u n t r e a t e d + 2 50  
+ •0  55
0
2 0 K  ( p H  7  0) s u o e r n a t a n t -8  25*  
+•0 11
100
pH  2 s u p e r n a t a n t •1 5  10
+ - 0  53
4 0
p H  2 p e l le t • 9  6 7 * -  
+-0 10
17
p H  4 s u p e r n a t a n t - 1 3  6 3 * -  
+-0 20
I C O 1
p H  4 pe l le t + 2 . 3 5 -  
+•0 12
20
p H  3 s u p e r n a t a n t + 2 3 3 -
t- 0  08
1001
p H  6 p e l le t -10 6 0 * -  
+-C 14
80
p H 8 s u o e r n a t a n t + 2 22 -
+-0 0 3
1002
p H  3 pe l le t -11 : r ~
* - 0  42
S O 1
p H  10 s u p e r n a t a n t . 4 n n * -  
+■0 24
80
p H  10 p e l le t - 0  0 4 * -
+ - 0  13
40
p H  12 s u p e r n a t a n t + 2 2 3 -  
+-0 17
• 17
p H  12 p e l le t + 6 4 2 ’ -  
+ -0 4 9
0
Ail ra is  w e r e  d o s e d  ai  0  3°:> ct  thei r b o d y  w e igh t  p er  d a y  lor  a d a y s  u n le s s  c i h e r w i s e  n o te d  T h e re  
w e r e  n =8 a n im a ls  p e r  g r c u p
'  = m e a n s  a re  s ign i f ican t ! /  d ' (e ren t  t ro m  va  ues  o b t a in e d  'c r  control  a n im a ls  (u n tre a te d .  P < 0  05 ) .
-  = m e a n s  an;  s igm 'icant iy  c  : fe rent  I ro m  v a 'u e s  o b t a in e d  tor a n im a ls  t re a te d  with u in l rac t io n a ted  
2 0 K  s u p e r n a t a n t
1 *  * i  morta lity afte r  two d a v s  c t  do s in g
2 » m o d a l i ty  a l te r  i d a y  o! O s i n g
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TABLE 6
Change in weight and mortality rates in chickens dosed with pH 
adjusted 20K supernatant extracts of Sesbania drummondii.
Treatment Fraction A Weight 
(% )
Mortality
(% )
Control +31.60
+-0.38
0
20K (pH 7.0) supernatant -32.60*
+-0 .11
1 0 0
pH 2 supernatant -32.60*1
+-0.57
2 0
pH 2 pellet +15.60*-
+-0.13
0
pH 10 supernatant -32.80*2
+-0.19
60
pH 10 pellet +19.10*-
+-0 .1 0
0
Values are the means +_ SEM for n=10 animals per group.
1= values calculated on only 4 animals per group.
2= values calculated on only 2 animals per group.
A Weight indicates the % change in weight from the initial predose weight.
* = significantly different from control values.
-  = significantly different from values obtained for animals treated with 20K supernatant.
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the pH 2 adjusted supernatant (Table 5), but this fraction produced 
only a 40% mortality compared with the untreated 20K supernatant 
(100% mortality). The pH 2 pellet was moderately toxic producing 
weight loss (-10% ) and 17% mortality. The pH 4 pellet showed little 
or no toxicity, whereas its supernatant counterpart caused 1 0 0 % 
m ortality w ithin 48 hours of the in itia l dose with a substantial 
weight loss (-13.6%). Despite the high mortality rate of the pH 6  
supernatant (100% within 48 hours), weight loss was not observed 
in animals receiving this fraction (-+3.0% ). The pH 6  pellet produced 
both a marked decline in weight (-1 0 .6 %) and a high mortality (80%). 
Like the pH 6  supernatant, the pH 8  supernatant produced no weight 
loss but caused 100% mortality w ithin 48 hours. For fractions 
treated at more alkaline pH's, weight loss was minimal but still was 
higher for supernatants compared with pellet fractions. Mortality 
continued to be high for the pH 10 supernatant fraction but declined 
to only 17% for the pH 12 supernatant. Pellet fractions were 
generally less toxic than their supernatant counterparts.
The upper and lower pH ranges for the toxicity of sesbania 
20K supernatants which had been used in rats (Table 5), were also 
examined in chickens. A similar pattern to what had been observed 
in sesbania treated rats was also seen in chickens, with the pellet 
fractions being far less toxic than the supernatants (Table 6 ; 
P<0.05). Once again, the unadjusted 20K supernatant produced 100% 
mortality w ithin four days in chickens and was accompanied by 
severe weight loss (Table 6 ). Similar weight losses were observed 
fo r an im als rece iving e ithe r pH 2 superna tan ts  or pH 10 
supernatants. Again, the m ortality was low with the pH 2
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supernatant (20%) and high with the pH 10 supernatant (60%). The 
corresponding pellet fractions produced a slower rate of weight gain 
compared with control birds (Table 6 ) but there was no associated 
mortality (Table 6 ). As had been observed in the rats, most of the 
toxicity could be recovered in the supernatants. The greatest weight 
loss was observed with the pH 2 supernatant, although this 
difference was not significant (P>0.05) when compared with weight 
loss in 2 0 K supernatant treated rats. Some species differences 
were noted, especia lly the substantial amount of w e ight loss
incurred by chickens undergoing treatment with pH 10 supernatants.
This fraction had not caused weight loss in the rat (Table 5).
D ia ly s is :
The adm in is tra tion of d ia lyzed extracts o f S e s b a n i a
drummondii to mature chickens significantly increased (P<0.05) the 
w eight loss com pared with those birds receiving non-dia lyzed 
extracts (Figure 5). After 3 days of dosing, there was an 8 % 
difference in weight loss (22% for dialyzed versus 14% for those 
animals receiving non-dialyzed extracts).
Concanavalin-A and Sephadex™ G-25:
The e ffects  of C oncanava lin -A  (Con-A, a lectin) and
Sephadex™ G-25 (G-25, a compound known to be bound by certain 
lectins) on the toxic ity  of sesbania extracts in chickens were 
determ ined. Toxicity , based on w eight loss, serum protein 
concentration and PChE activity, was reduced after either Con-A or 
G-25 treatment (Table 7). Following treatment, the 20K supernatant
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Figure 5 : The effect of dialysis on the toxicity of who le  sesbania  extracts.
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TABLE 7
Protein, PChE and weight changes in chickens treated with 20K 
supernatant fractions and 20K fractions that had been treated with 
either Sephadex™ G-25 or Concanavalin A Sepharose.
Treatment Protein
(mg/ml)
PChE
(units)
A Weight
(% )
Control 3.40 0.081 +27.10
+-0.08 +-0 .0 0 0 +-1.44
20K 2 .0 0 * 0.029* -18.30*
+-0 .1 0 +-0 .0 0 1 +-1.18
Con A 3.00- 0.041*- + 9.30*-
+-0 .0 2 +-0 .0 0 1 +-0 .6 6
Seph.™ G-25 3.00- 0.044*- +19.30*-
+-0 .01 +-0 .0 0 1 +-1.28
Values are means +-SEM for n=6 animals per group.
Controls were untreated. Treated animals were dosed for 4 days at 1% of their body weight/day.
PChE units are expressed as nanomoles of substrate converted per minute per mg of enzyme.
A Weight is the percentage change in weight after 4 days from the initial predose weight.
Con A = Concanavalin A-Sepharose mixed as a slurry with the extract and stirred at room 
temperature for 2 hours, then filtered through Whatman#1 filter paper.
Seph. ™G-25 = Sephadex™G-25 treated as a slurry in an analogous manner to the Con A 
experiment.
* = means are significantly different (P<0.05) from values obtained for control animals.
~ = means are significantly different (P<0.05) from values obtained for 20K treated animals.
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no longer significantly lowered serum protein concentrations. PChE 
activity, after dosing with treated extracts, remained at about 1 /2  
control values regardless of the treatment. However, these values 
were significantly above those obtained for animals receiving the 
untreated 20K supernatant (P<0.05). T reatm ent of the 20K 
supernatant with Seph. G-25 reversed the weight loss although the 
average chicken weight remained at about 71% of control (untreated) 
animals. Con-A treatment also diminished the weight loss induced 
by 20K supernatant (34% of the control value).
T e m p e ra tu re :
The effects of freezing and freezing followed by dialysis on 
the toxicity of 2 0 K supernatants were examined in rats (Table 8 )., 
Although weight loss was less in animals receiving frozen extracts 
(-18.3%  versus -9.1%  for 20K and frozen 20K supernatants, 
respectively), declines in serum protein concentration (4.64 and 
4.00, respectively) and PChE activity (0.618 and 0.497, respectively) 
were larger than for those receiving unfrozen extracts of sesbania. 
Dialysis of a previously frozen extract was found to produce an 
extract which was much less toxic than the original frozen extract 
(Table 8 ). S im ilarly, lyophilization reduced both the degree of 
weight loss and the decline in PChE activity observed with the 20K 
supernatant (Table 8 ). In contrast, the lyophilized 20K supernatant 
produced a decrease in serum proteins greater than that achieved by 
the untreated 20K supernatant. Extracts of sesbania were shown to 
have no direct effect on the activity of purified horse serum PChE or
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TABLE 8
The influence of freezing on the toxicity of the 20K supernatant 
fraction in rats.
Treatment AWeight
(%)
Protein
(mg/ml)
PChE
(units)
Control +18.17 5.86 0.836
+-1.21 +-0.04 +-0.004
20K -18.30* 4.64* 0.618*
+-1.38 +-0.03 +-0 .0 0 2
Frozen -9.13*~ 4.00*~ 0.497*-
+-0.17 +-0.04 +-0.003
Frozen/Dialyzed -4.10*- 5.40- 0.513*-
+-0.37 +-0.03 +-0 .0 0 2
Lyophilized -1.53*- 4.14*- 0.882-
+-1.25 +-0.05 +-0.009
Values are means +- the SEM for n= 8 animals per group.
Control animals were untreated. Rats were dosed at 0.5% of their body weights/day for three 
days.
PChE units are expressed as nanomoles of substrate converted per minute per mg of protein.
A Weight indicates the percentage change in weight at day 3 from the initial predose weight.
* = means are significantly different (P<0.05) from values obtained for control animals.
~= means are significantly different (P<0.05) from values obtained for 20K treated animals.
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electric eel AChE as well as partially purified rat brain PChE (not 
shown).
The ability to induce weight loss was completely lost when 
20K supernatants were heated for one hour at either 50 or 80C (data 
not shown). Similarly, heating the extracts resulted in a loss of the 
ability to induce decreases in serum protein concentration in both 
chickens and rats. Values were obtained that were not significantly 
below values obtained for control (untreated) animals (Table 9). 
PChE activity remained below control values following heating but 
were significantly higher than the values obtained from animals that 
had received whole sesbania extract. In the rat, heated sesbania 
extracts caused a greater decline in serum protein concentrations 
than did untreated extracts (Table 9). As had been observed for the 
chicken, heated sesbania extracts continued to cause decline in 
PChE activity compared with control values but this decline was 
significantly less than that observed for the whole unheated extract 
(Table 9).
A garose:
Treatm ent of 20K supernatants with agarose reduced the 
degree of weight loss determined after 2 days of treatment (Figure 
6 ). The toxicity of the extract could not be restored by eluting the 
sesbania treated agarose with alpha-methyl-glucoside. In all cases, 
these treatments reduced overall weight loss compared with those 
chickens receiving the untreated 20K supernatant extracts (Figure 
6 ).
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TABLE 9
Serum proteins and PChE activity in chickens and rats dosed with 
heated extracts of Sesbania drummondii.
Treatment
CHICKEN
Serum PChE  
Protein (units) 
(mg/mi)
Serum
Protein
(mg/ml)
RAT
PChE
(units)
Control 3.28 1.088 5.97 0.861
+-0.05 +-0.005 +-0.08 +-0.006
Whole Extract 2.35* 0.256* 4.10* 0.160*
+-0.14 +-0.004 +-0.08 +-0.003
50C. 3.06 0.496*~ 3.43*~ 0.538*~
+-0.14 +-0 .0 0 2 +-0.06 +-0 .0 0 2
80C. 3.10 0.513*~ 3.50*~ 0.685*~
+-0.19 +-0.017 +-0 .0 2 +-0 .0 0 1
Values are the means +- the SEM for n=6 animals per group.
Whole extract = ground filtered seeds and pods of sesbania
50C or 80C = treatment temperature at which whole extract was subjected for 60 minutes.
Controls were untreated. Rats were dosed for 4 days at 0.5% and chickens dosed at 1.0% of 
their body weight/day.
* = means are significantly different from values obtained for control animals (P<0.05).
~ = means are signifcantly different from values obtained for animals receiving whole extracts 
(P < 0 .05 ).
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Figure 6 : The efiects of agarose and alpha mthyl-glucoside treatments on the toxicity of whole 
sesbania extracts in the chicken
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M olecular W eight:
Molecular weight fractionation of 20K supernatants showed 
that the >1000 MW fraction failed to produce weight loss in treated 
chickens (Table 10), although animals receiving this extract did not 
gain weight as rapidly as did control chickens (+25.9% and +53.7%, 
respectively). Weight loss in chickens was observed when treated 
with a <1000 MW fraction (-41.5%, Table 10). The <1000 MW 
fractions demonstrated greater weight loss than did the <500 MW 
fraction (Table 10). M ortality was highest for those animals 
receiving the 20K supernatants (100%) followed by the <1000 MW 
(8 6 %) and then the <500 MW fraction (67%, Table 10). The >1000 MW 
fraction produced zero mortality (Table 10). Compared with the 
control values s ign ificant decreases (P<0.05) in serum protein 
concentrations were achieved in those animals who had received the 
>1000 MW (2.64mg protein/ ml of serum [mg/ml]), the <500 MW (2.33 
mg/ml) and the <1000 MW fractions (2.64 mg/ml). These values 
were significantly above (P<0.05) the values obtained for the 20K 
supernatant treated an im als (2 .0 0 ), but remained s ign ifican tly  
below (P<0.05) values obtained for control (untreated) animals (3.75 
m g/m l).
Serum PChE activ ity  was unaltered in those animals 
receiving the >1000 MW fractions (Table 9). Those animals, which 
had been dosed with the <1000 MW fraction, showed significant 
declines in PChE activ ity  (0.072, P<0.05). This value was 
proportionately less but still significant (P<0.05) for those animals 
receiving the <500 MW fraction (0.109, , P<0.05, Table 10). The 
overall toxic ity of the <500 MW fraction was less for the three
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TABLE 10
Com parison of % w eight, m orta lity , serum  protein and 
pseudocholinesterase changes induced by ultrafiltration extracts of 
the 20K supernatant in chickens.
Treatment AWelght
(% )
TOXICITY
Mortality
(% )
Protein
(mg/ml)
PChE
(units)
Control +53.73
+-0 .2
0 a 3.75
+-0 .0 2
0.164
+-0.009
20 K -3 4 .2 * b 
+-0.3
1 0 0 b 2 .0 0 *
+-0.03
0.091*
+-0 .0 0 1
>1000 MW +25.9*~a
+-0.3
0 a 2.64*-
+-0 .0 1
0.171-
+-0.006
<1000 MW -41.5*~a 
+-0.4
8 6 a 2 .0 0 *
+-0.04
0.072*-
+-0 .0 0 1
<500 MW -19.9*~c
+-0 .2
67° 2.33*-
+-0.03
0.109*-
+-0.003
Values are means +- the SEM for n = 10 animals per group.
Control animals were untreated. Ten day old chicks were dosed at 0.5% of body weight/day for 
six days. The chickens were dosed for three days with the 20K extract and for 4 days with the 
<500 MW fraction.
Molecular weight fractions were as follows: >1000 and < 1000 separated from the 20K extract by 
an Amicon hollow fiber device. The <500 MW fraction was separated from the <1000 fraction by 
the use of an Amicon YC 0.05 membrane.
A Weight is the % change change in the weight at day six from the initial predose weight.
% Mortality is calculated after six days of dosing except as follows: a= mortality at day 6 of dosing; 
b= mortality at day 3 of dosing; c = mortality at day 4 of dosing
PChE units are expressed as the nanomoles of substrate converted per minute per 
mg of protein.
* = means are significantly different from control values (P<0.05).
~ = means are significantly different from 20K supemate values (P<0.05).
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parameters examined (i.e. weight loss, serum protein concentration 
and PChE activity) compared with the <1000 MW fraction.
C y c lo h e x im id e :
The patho log ica l fea tures observed during cyclohexim ide 
poisoning or sesbania intoxication of treated rats are shown in Table 
11 A. The general pathology was sim ilar for both compounds. 
However, important d ifferences between the two treatm ents were 
noted especially in the histopathology (Table 11 A). Serum protein
concentrations were lowest for those animals receiving sesbania 
extracts (Table 11B). The decline in PChE activity for those animals 
receiving the sesbania extracts was greater than for those animals 
treated with either concentration of cyclohexim ide (Table 11B). 
PChE activity was decreased by both doses of cycloheximide tested 
but this decrease was not dose related. The activity of this enzyme 
was lower for sesbania treated animals than either cycloheximide or 
control animals (Table 11B).
H is to lo g ic a l and e le c tro n  m ic ro sco p ic  exa m in a tio ns  
elucidated further differences between cyclohexim ide and sesbania 
trea tm ents. No changes were observed in the h isto log ica l 
appearance of liver removed from rats that had been treated with 
sesbania compared with control animals (Figure 7, 8 ). However, 
extreme vacuolization was observed in liver obtained from animals 
that had been dosed with 30% of the LD5 0  of cyclohexim ide (Figure
9). No changes could be detected in sesbania treated cells in thin 
section (Figure 10, 11), with the possible exception of some slight 
vacuo- lization. Once again, those animals that had been treated
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TABLE 11A
Comparison of the pathology induced by cycloheximide and crude 
extracts of Sesbania drummondii in rats - pathology.
C o n tro l G xolotioxLm ldo
10% LDgg
Cycloheximide 
30% LD5 Q
SesJbania
Whole
Extract
weight moderate greatest moderate
gain weight loss weight loss weight loss
normal gut hyperemia gut hyperemia gut hyperemia
normal engorged engorged engorged
stomach stomach stomach
Histo: liver Histo: liver Histo: liver Histo: liver
normal vacuolization extreme
vacuolization
normal
Obervations on n=6 animals per group except for EM studies where only three animals were 
examined per group.
Cycloheximide in chickens gave identical results except that no electron microscopic or 
histological examinations were undertaken.
Protocol: Since sesba mide isolated from Sesbania drummondii has been reported to share 
some structural similarities to glutaride-like antibiotics and pure sesbanimide was unavailable, rats 
were dosed with 10% (0.18 mg / kg per day) or 30% (0.54 mg / kg per day of the LD50 of 
cycloheximide in rats and the pathology compared to a group of rats that had received whole 
sesbania extracts. All animals were dosed for three days.
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TABLE 11B
Comparison of the pathology induced by cycloheximide and crude
extracts of Sesbania drummondii in rats - serum
c h e m is try .
Treatment Serum Protein 
(mg/ml)
PChE Activity 
(units)
Control 4.62 0.370
+-0.23 +-0 .2 0 0
1 0 % l d 50 4.48- 0.170*-
cycloheximide +-0.26 +-0.015
30% LD50 4.28- 0.171*-
cycloheximide +-0.57 +-0.004
Whole Extract 3.75* 0.148*
+-0.31 +-0.003
General serum chemistry for n=6 animals per group.
Cycloheximide in chickens gave identical results except that no electron microscopy or 
histological work was undertaken.
PChE units are expressed as nanomoles of substrate converted per minute per mg of protein.
* = means are significantly different (P<0.05) from values obtained for control animals.
~ = means are significantly different (P<0.05) from values obtained for animals receiving sesbania 
extracts.
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Figure 7: Histological section of control rat liver stained with Hematoxylin A III and Eosin Y for 25 
minutes each. 1800 x magnification
A - nucleus 
B- sinusoidal space
Figure 8 : Histological section of liver from sesbania treated rats stained with Hematoxylin III and 
Eosin Y for 25 minutes each. 1600 x magnification.
A- nucleus 
B- sinusoidal space
m
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Figure 9: Histological section of liver from cycloheximide (30% LD 50) treated rats stained 
with Hematoxylin III and Eosin Y for 25 minutes each. 1600 x magnification.
A - nuclues 
B- lumen 
C - vacuolization
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Figure 10: Thin section transmission electron photomicrograph of control rat liver post-fixed in 
osmium tetraoxide and stained with 1% uranyl acetate. Final magnification is 45,000.
A - mitochondrion
B- dark staining inclusion body (possibly lipid)
C- small vacuole
Figure 11: Thin section transmission electron photomicrograph of liver from sesbania treated rats 
post-fixed in osmium tetraoxide and stained with 1% uranyl acetate. Final magnification is 22,500.
A - nuclues
B - dark staining inclusion body (possibly lipid)
C- Golgi ?
D- small vacuole
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with cyclohexim ide displayed a com plete ly d iffe ren t appearance 
(Figure 12). TEM (transimission electron microscopy) confirmed the 
extreme vacuolization in itia lly  observed in histological sections. 
These distended vacuoles were filled with a flocculant precipitate.
S esban im ide:
Sesbanimide was lethal to 6 day old chicks (average chick 
weight 50 to 70 gm) at a concentration of 0.25mg / ml. Each bird 
received 1 ml of this sesbanimide solution via gavage. Birds dosed 
at this concentration exhib ited substantia l weight loss (15%), 
decreased serum protein concentrations (42% of control) and 
decreased PChE activity (28% of control, data not shown). This was 
accompanied by generalized weakness and smooth muscle inhibition 
as evidenced by the full and distended appearance of the crops of 
treated birds. There was 100% m orta lity  w ith in 24 hours. 
Sesbanimide made up in BBN buffer and kept refrigerated continued 
to cause mortality in chickens for up to seven days even at a reduced 
dose of 1.04 mg / kg chick weight.
Sesbanimide treated birds displayed all of the clinical signs 
associated with sesbania toxicosis except that the onset of death 
was extremely rapid. Thin layer chromatography on silica plates, 
followed by charring with sulphuric acid, indicated that sesbanimide 
might be present in crude extracts of sesbania. Pure sesbanimide 
was found to be too labile for analysis by gas chromatography. 
HPLC monitoring gave the following results: pure sesbanimide gave 
two peaks, a minor peak at 7.4 minutes and a major peak at 9.56 
minutes retention time. The height of the minor peak was increased
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Figure 12: Thin section electron photomicrograph of liver from cycloheximide (30% LD 50) 
treated rats post-fixed is osmium tetraoxide and stained with 1% uranyl acetate. Final
magnification is 20,000 
A - mitochondria 
B - moderately large vacuole 
C- vacuole with flocculant precipitate 
(possibly protein)
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when sesbanimide was permitted to stand in aqueous solution at 4C 
for 3 days. HPLC analysis of a partially purified sesbania extract 
(Figure 2) contained eight separate peaks. The most abundant peak 
had a retention time of 7.35 minutes and was sim ilar to the minor 
peak found in the purified sesbanimide preparation. On the basis of 
re lative peak heights, the partia lly  purified sesbania extract 
contained 22.3 times the concentration of the 7.4 minute peak found 
with the sesbanimide sample (minor sesbanimide peak). The only 
other peak from the partially purified sesbania extract comparable 
to the sesbanimide sample corresponded to a retention time of 9.79 
minutes. This would represent about 1/3 the total concentration of 
the major peak in the sesbanim ide sample. However, when 
com parisons were made for relative toxicity (estim ated on the 
ability  of e ither sesbanim ide or the partia lly  purified sesbania 
fraction to cause death), the <500MW fraction was found to be far 
less toxic (30% mortality) when compared with the sesbanim ide 
preparation (100% mortality). Under these conditions, doses were 
calculated on the basis of equivalent HPLC peak heights.
Sesbanimide would not crystallize from the partially purified 
sesban ia  e x tra c t from  a m ix tu re  of hot m ethanol and 
dichlorom ethane nor was the toxicity of the extract maintained
under these conditions.
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Studies on the Mechanisms of Sesbania Actionfs) : 
P ath o p h ys io lo g y:
The common patho log ica l find ings in rats and chickens 
treated with extracts of Sesbania drum m ondii included depression 
and listlessness. The body fat of affected chickens and rats was 
alm ost entire ly depleted. The eyes of treated individuals were 
commonly exudous and accompanied by some crustiness. All animals 
had cold extrem ities although their body temperatures remained 
normal over the 4 day dosing regimen (not shown). Postmortem 
exam ination showed a distended, bloated stomach. The lower 
gastrointestinal tract was hyperemic and empty with vasodilatation. 
These gastrointestinal changes were accompanied by diarrhea. The 
hematocrits of sesbania treated chickens and rats were frequently 
depressed. Other postmortem observations were an extremely 
friable, mottled liver and frequently the kidneys of treated rats 
were gun-metal gray with occasional mottling.
In chickens, the signs o f terminal sesbania poisoning included 
behavioral deficits, especially an inablility to stand or hold up their 
heads. The combs of male birds were frequently discolored, swollen 
and flaccid. In the term inal stages, birds displayed rapid shallow 
breathing. The feathers were ruffled and the birds died without 
struggle. There was generalized muscular wasting in chickens, 
particu larly of the pectoral muscle which was often translucent. 
The leg muscles of sesbania treated chickens were wasted and dark 
in color with multiple petechial hemorrhages. The crops of birds 
treated with sesbania extracts were full and these birds invariably
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regurgitated mucus when handled, particularly after the second day 
of dosing. The gall bladders of affected birds were turgid. At 
necropsy, the tissues of treated birds appeared dehydrated.
W eight Loss:
In chickens, weight loss in response to sesbania treatment 
was evident from the first day of dosing (Table 12). In rats, which 
received one half the dose administered to chickens (0.5% versus 
1.0% of the body weight/day), significant weight loss did not occur 
(P>0.05) until day three of dosing. However, weight gain in sesbania 
treated rats was significantly below (P<0.05) that of controls by 
day two of dosing (Table 12).
In parallel with weight loss, the liver weights of sesbania 
treated rats and chickens were found to be lowered in comparison 
with control animals (Table 13). However, in spite of comparable 
decreases in both body weight and liver weight, the liver to body 
weight ratios remained relatively constant with treatm ent (Table 
14). In the chicken, sesbania treatm ent elevated the cytosolic 
pro te in /live r w eight fraction (Table 14) with only a slight non­
significant (P>0.05) increase in the microsomal protein/liver weight 
ratio. Rats undergoing sesbania treatment showed a reversal in this 
pattern of protein ratios. The microsomal protein / liver ratio was 
found to be significantly higher (P<0.05) than the values obtained for 
control animals. The slight increase in the cytosolic / liver ratio 
from sesbania treated rat liver was not significant (P>0.05, Table
14).
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TABLE 12
Comparison of weight change induced by crude extracts of 
Sesbania drummondii in chickens and rats.
CHICKEN RAT
A Weight
(%)
Control Treated Control Treated
Day 1 5.50 -3.12* 15.00 11.11
+-0.20 +-0.23 +-0.40 +-0.64
Day 2 9.93 -4.97* 30.33 12.45*~
+-0.24 +-0.29 +-0.06 +-0.18
Day 3 18.59 -10.65* 36.00 -6.20*
+-0.43 +-0.29 +-0.56 +-0.10
Day 4 23.69 -16.89* 44.00 -8.00*
+-0.60 +-0.45 +-0.83 +-0.93
Values are the means +- the SEM for n = 22 chickens and n = 6 rats per group.
Controls were untreated for both species. Chickens were dosed at 1.0% of the body weight/day 
while rats received 0.5% of the body weight/day for four days.
A Weight indicates the % change in weight at each day from the initial predose weight. Toxicity is 
reported as the A% weight change from the initial weight.
* = means are significantly different from the values obtained for control animals (P<0.05).
~ = means are significantly different from the previous day's weight change (P<0.05).
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TABLE 13
Comparisons of liver weights in chickens and rats dosed with 20K 
supernatant fractions of Sesbania drummondii.
Liver Weight 
(gms)
CHICKENS RATS
Control Treated Control Treated
8.74 6.64* 13.02 9.28*
+-0.09 +-0.03 +-0.37 +-0.48
Values are the means +- the SEM for n= 22 chickens and n= 9 rats per group.
Controls were untreated for both species. Chickens were dosed at 1.0% body weight / day for 
three days while rats were dosed at 0.5% of body weight / day.
* = means are significantly different from values obtained for control animals (P<0.05).
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TABLE 14
Comparison of liver protein to liver weight ratios in chickens and 
rats dosed with 20K superantant fractions of Sesbania drummondii.
Liver Protein / Liver Weight Ratio 
(mg microsomal or cytosolic protein / gm liver weight)
Chickens Rats
Control Treated Control Treated
Microsomes
2.56 2.78 0.44 1.73*
+-0.04 +-0.04 +-0.02 +-0.05
Cytosol
5.51 6.84* 1.32 1.39
+-0.00 +-0.01 +-0.00 +-0.00
Values reported as the mean +- the SEM tor n=l2 chickens per group and n = 6 rats per group.
Control animals were untreated. Chickens were dosed at 1.0% of their body weight /day for three 
days while rats were dosed at 0.5% of their body weight/day.
* = means are signifcantly different from values obtained for control animals (P<0.05).
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Serum sodium concentrations were unchanged in chickens, 
but were significantly lowered in sesbania treated rats (P<0.05, 
Table 15). In contrast, there was a s ign ifican t decrease in 
potassium concentration in sesbania treated chickens (P<0.05, Table
15) which was not observed in sesbania treated rats. The blood pH 
of treated chicken was significantly increased (alkaline, P<0.05) but 
s ign ifican tly  depressed (acidic, P<0.05) in blood obtained from 
sesbania treated rats.
The blood from treated animals showed a greater tendency
tow a rd
hemolysis than did blood obtained from untreated animals. The blood 
hem atocrit was depressed in both treated chickens and rats. 
However, th is decrease was only sign ificant (P<0.05) for blood 
obtained from sesbania treated chickens (Table 15).
E le c tro p h o re s is :
Table 3 shows that serum protein concentrations fell in 
response to sesbania treatment in both chickens and rats. Serum 
from sesbania treated chickens showed decreased albumin (Table
16). The alpha 1 fraction fell slightly while the alpha 2 fraction 
rose slightly in response to sesbania treatment. The beta fraction 
rose somewhat in the chicken follow ing sesbania treatment. The 
gamma globulin concentration fell. Changes were observed in the 
serum of sesbania treated rats (Table 17) due mainly to the 
depletion of the albumin fraction. Prealbumin represented a 
substantial fraction in the sesbania treated rats whereas it had been 
neglig ible in control rats (Table 17). The a lpha l fraction was
74
TABLE 15
Sesbania induced changes in serum and blood parameters in 
chickens and rats.
CHICK E-MS. RATS
Control Treated Control Treated
Na+ meq 146.00 145.62 139.67 136.00*
+-0.22 +-0.24 +- 0.06 +- 0.01
K+ meq 4.61 3.05* 6.47 6.63
+-0.10 +-0.06 +- 0.03 +- 0.01
pH 7.355 7.598* 7.392 7.239*
+-0.007 +-0.002 +- 0.002 +-0.007
Hematocrit 42.67 36.77* 38.10 36.95
+-0.36 +-0.68 +- 0.14 +- 0.12
Values are the means +- the SEM for n = 9 chickens per group. Rat values are for n = 30 animals 
per group except for pH values where n = 5 animals per group and hematocrit where n = 10 
animals per group.
Control animals were untreated. Chickens were dosed at 1.0%, rats at 0.5% of their body weights 
/ day , respectively for three days.
* = means are significantly different from the values obtained for control animals (P<0.05).
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TABLE 16
Electrophoretic profile of control chicken serum and serum derived 
from animals that had been treated with 20K supernatant sesbania 
extracts.
Fraction
TOTAL PROTEIN
(% )
Control Treated
Albumin 50.3 37.1*
+-2.7 +-3.2
Alpha 1 9.3 7.7
+-0.8 +-0.3
Alpha 2 11.1 16.8*
+-1.3 +-0.9
Beta 19.4 25.2*
+-2.1 +-2.3
Gamma 6.5 3.2*
+-0.7 +-0.9
Values expressed as % of the total protein for n=6 chickens per group. Initial protein 
concentrations are not idential for both control and treated chickens but are representative of the 
distribution of serum proteins between the two groups.
Controls were untreated. Chickens were dosed for three days at 1.0% of body weight/day for 
three days.
* = means are significantly different from control values (P<0.05).
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TABLE 17
Electrophoretic partition of control rat serum and serum derived 
from rats treated with 20K supernatant extracts of S e s b a n i a  
drummondii.
Fraction
TOTAL
Control
PROTEIN
(% )
Treated
Prealbumin 0.3 12.5*
+-0.2 +-4.6
Albumin 56.7 43.5*
+-2.2 +-1.5
Alpha 1 15.0 9.9*
+-1.2 +-0.6
Alpha2 4.8 10.9*
+-1.1 +-0.6
Beta 1 13.1 9.6
+-2.0 +-0.7
Beta 2 9.0 9.6
+-1.5 +-0.6
Gamma 4.0 3.4
+-0.5 +-0.3
Values are reported as the % of the total protein for n = 35 animals per group.
Controls were untreated. Treated rats received 0.5% of the body weight/day of sesbania extracts 
for three days.
* = means are signficantly different from the values obtained for control animals (P<0.05).
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decreased while the alpha 2 fraction increased following sesbania 
treatment in the rat. Neither the beta nor the gamma fractions 
were significantly changed by sesbania treatment in the rat. It is 
im portant to note that while the absolute protein concentrations 
were not identical between control and sesbania treated animals, 
the relative proportions of each class were independent of the total 
protein concentration. These concentrations were about one half 
control values for both sesbania treated chickens and rats.
Im m u n o d iffu s io n :
In both chickens and rats, the total protein and albumin 
concentrations were significantly (P<0.05) depressed by sesbania 
treatment (Table 18). The percentage decrease for both chickens 
and rats was greatest for the albumin fraction (being 42% and 52% 
of control values, respectively).
Serum Enzvm es: 
PChE and AChE:
The e ffects  of sesban ia  trea tm e n t on serum  PChE 
(Pseudocholinesterase) and AChE (Acetylcholinesterase) activities 
are given in Table 19. The activities of chicken serum PChE and 
AChE were depressed in sesbania treated birds, whereas in sesbania 
treated rats only serum PChE activity was depressed. Serum AChE 
activity in the rat remained unaltered by sesbania treatment (Table 
19).
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TABLE 18
The estimation of total protein and albumin concentrations in serum 
from control (untreated) and sesbania treated animals by radial 
immunodiffusion.
CHICKENS RATS
Whole Serum Albumin Whole Serum Albumin
(mg/ml) (mg/ml) (mg/ml) (mg/ml)
Control Control Control Control
3.50 1.76 7.10 3.61
+-0.10 +-0.12 +-1.10 +-0.82
T reated T reated Treated Treated
2.14* 0.74* 5.20* 1.88*
+-0.05 +-0.08 +-1.50 +-0.09
Values are the means +- the SEM for n = 6 animals per group.
Control animals were untreated, while treated chickens received sesbania extracts at 1.0% and 
rats at 0.5% of body weight / day for three days.
* = means are significantly different from values obtained for control animals (P<0.05).
79
TABLE 19
Serum PChE, AChE, LDH, alkaline phosphatase and gamma 
glutamyl transpeptidase activities in chickens and rats dosed 
withSeshan/a drummondii.
Enzyme Control
RAT
Treated
CHICKEN  
Control Treated
PChE 1.47 1.05* 1.40 0.80*
+-0.02 +-0.01 +-0.00 +-0.00
AChE 0.59 0.64 0.56 0.32*
+-0.03 +-0.05 +-0.01 +-0.00
LDH 128.00 27.20* 169.37 142.17*
+-0.74 +- 0.39 +-1.36 +-1.99
APase 63.45 31.98* 43.55 14.17*
+-0.75 +-0.89 +-0.19 +*0.07
GGT 5.00 3.00* 4.28 2.09*
+- 0.40 +- 0.34 +- 0.20 +- 0.16
Values are the means +- the SEM for n = 6 animals per group.
Control animals were untreated. Treated chickens received sesbania extracts at 1.0% of the body 
weight / day while rats were dosed at 0.5% of the body weight / day for three days.
PChE = serum pseudocholinesterase activity as nanomoles of substrate converted per minute 
per mg of protein.
AChE = acetylcholinsterase activity measured in an analogous manner as PChE using acetyl 
thiocholine iodine as substrate.
LDH = serum lactic dehydrogenase activity as nanomoles of substrate converted per minute per 
mg of protein.
APase = alkaline phosphatase activity expressed as nanomoles of para-nitrophenyl phosphate 
converted per minute per mg of protein.
GGT = gamma glutamyl transpeptidase activity expressed as nanomoles of substrate converted 
per minute per mg of protein.
* = means are significanlty different from control values (P<0.05).
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Phenobarbital pretreatment did not alter the activity of the
PChE fraction in controls (Table 20) but did partially reverse the
sesbania induced decrease in PChE activ ity . BNF (b e t a - 
naphthaflavone) trea tm ent s ign ifican tly  (P<0.05) increased the 
activity of PChE compared with control animals as well as partially 
reversed the sesbania induced change in this enzyme (Table 20).
A lkaline Phosphatase, G lutam yl Transpeptidase and Lactic  
Dehydrogenase:
The serum activities of alkaline phosphatase (APase) and 
gamma glutamyl transpeptidase (GGT) were depressed in the serum 
of sesbania treated chickens (Table 19), but LDH activ ity was 
unchanged. In the rat, changes in serum lactic dehydrogenase, 
alkaline phosphatase and gamma glutamyl transpeptidase activities 
in response to sesbania treatment were depressed (Table 19).
Liver Enzvm es:
L iver C ho linesterase:
Liver PChE activities in rat and chicken are given in Table 21.
In the chicken, the activity of PChE was about equally distributed
between the cytosolic and microsomal fractions. However, in the 
rat, the cytosolic activ ity represented the major fraction of the 
enzym e in the liver. Despite these species d iffe rences in 
distribution, sesbania was found to significantly (P<0.05) depress 
the activity of liver PChE in both cytosol and microsomes (Table 21).
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TABLE 20
The influence of phenobarbital and beta-naphthaflavone (BNF) on 
circulating rat serum total (pseudo + true) cholinesterase activity.
Total ChE 
(units)
Control 0.99
+-0.00
Sesbania 0.44*
+-0.00
Phenobarbital 1.01-
+-0.01
Phenobarbital/Sesbania 0.76*-
+-0.00
BNF 1.40*-
+-0.04
BNF/Sesbania 1.13*-
+-0.04
Values are the means +- the SEM for n = 6 animals per group.
Control animals were untreated. Rats were dosed for 3 days with phenobarbital (80mg/kg) or BNF 
(40 mg/kg). Combination treatments were dosed for an additional two days with sesbania at 0.3% 
of the body weight / day.
Total ChE units are expressed as the nanomoles of butrylthiocholine iodine converted per minute 
per mg protein.
* = means are significantly different from values obtained for control animals 
(P<0.05).
~ = means are significantly different from values obtained for animals receiving sesbania extracts 
(P<0.05).
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TABLE 21
Liver pseudocholinesterase activity in chickens and rats treated 
with 20K supernatant extract of Sesbania drummondii.
Control
PChE Activity 
(units) 
CHICKEN  
Treated Control
RAT
Treated
Microsomes 1.30 0.84* 0.05 0.03*
+*0.00 +-0.01 +-0.00 +-0.00
Cytosol 1.39 0.61* 1.35 1.10*
+-0.02 +-0.00 +-0.02 +-0.03
Values are the means +- the SEM for n = 19 animals for chickens and n = 6 animals for rats per 
group.
All animals were dosed for three days prior to sacrifice, chickens at 0.5% of the body weight and 
rats at 0.3% of the body weight/day.
PChE units are expressed as the nanomoles of substrate converted per mg of protein at 22C.
* = means are significantly different from values obtained for control animals (P<0.05).
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Liver AChE activities in rat and chicken are shown in Table 
22. AChE activity was sim ilarly distributed in both chickens and 
rats and did not show any species variation in distribution (Table 
22). Sesbania treatment produced decreases in AChE activities in 
both microsomes and cytosol for treated rats and chickens (P<0.05).
Liver Lactic Dehydrogenase:
Table 23 gives the data for liver LDH activ ities in both 
chickens and rats. For both species, sesbania treatments produced 
decreased microsomal activ ities (-50%  of control values). The 
cytosolic fraction, representing the major portion of the enzyme 
activity, was unaffected by sesbania treatment (Table 23).
Liver Pyruvate Kinase:
The effects of sesbania trea tm ent on the activ ities of 
pyruvate kinase in chickens and rats are shown in Table 24. 
Pyruvate kinase (PK), an allosteric liver enzyme in rats, associated 
with the metabolism of carbohydrates, is stimulated by the addition 
of fructose (bis) 1,6 diphosphate (FBP). The PK activities in the 
liver were approxim ately equally distributed between the cytosol 
and microsomes in both chickens and rats (Table 24). For the rat, 
sesbania treatment was found to remove about 50% of the activity. 
This depression remained both in the presence and absence of FBP 
stimulation though absolute enzyme activ ities were increased by 
FBP for both control and sesbania treated rats. In the chicken, the 
degree of stimulation by FBP was much less dramatic. In both 
control and treated chickens, FBP addition increased the overall
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TABLE 22
Aceylcholinesterase activity in the livers of chickens and rats 
treated with 20K supernatant extracts of Sesbania drummondii.
AChE Activity
CHICKENS .RAIS
Control Treated Control Treated
Microsomes
0.12 0.05* 0.19 0 . 01*
h— 0.00 + - 0.00 + - 0.00 + - 0.00
Cytosol
0.56 0.36* 0.54 0.34*
+-0.03 + - 0.02 + - 0.01 + - 0.00
Values are the means +- the SEM for n = 6 animals per group.
Control animals were untreated. Animals were dosed for three days at 1.0% of body weight for 
chickens, while rats were dosed at 0.5% of body weight /day.
Microsomes and cytosol were 100,000 x g  superantant (cytosol) and washed pellet (microsomes) 
fractions, respectively, from isolated liver samples.
* = means are significantly different from values obtained for control animals (P<0.05).
85
TABLE 23
Lactic dehydrogenase activity in the livers of chickens and rats 
treated with 20K supernatant extracts of Sesbania drummondii.
LDH Activity 
(units)
CH IC KENS RATS
Fraction Control Treated Control Treated
Microsomes 29.89 16.63* 44.58 20.31*
+-0.43 +- 1.53 +-0.81 +-0.51
Cytosol 173.08 165.71 134.60 129.73
+-4.73 +-10.60 +-4.82 +-9.93
Values are the means +- the SEM for n = 22 animals per group for chickens and n = 15 animals per 
group for rats.
Control animals were untreated. Chickens were dosed at 1.0% of the body weight / day for 3 
days, while rats were also dosed for three days but at 0.3% of the body weight.
Microsomes and cytosol are the 100,000 x g supernatant and washed pellet fractions, 
respectively, obtained from isolated liver.
* = means are significantly different from values obtained for control animals (P<0.05).
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TABLE 24
Pyruvate kinase activity in the livers of chickens and rats 
undergoing treatment with sesbania extracts.
Fraction
PK
(units)
CHICKEN  
Control Treated
RAT
Control Treated
Microsomes 0.072 0.056* 0.169 0.075*
+-0.001 +-0.001 +-0.000 +-0.000
Microsomes 0.083- 0.086-° 0.705- 0.335*-
+FBP +-0.001 +-0.003 +-0.006 +-0.003
Cytosol 0.056 0.042* 0.149 0.106*
+-0.001 +-0.001 +-0.001 +-0.001
Cytosol 0.076- 0.062*- 0.157- 0.110*-
+FBP +-0.000 +-0.000 +-0.001 +-0.000
Values are the means +- the SEM for n = 6 animals per group.
Control animals were untreated. Rats were dosed at 0.5% of the body weight/day while chickens 
received 1.0% of the body weight/day. Each group was dosed for three days.
Microsomes and cytosol are the 100,000 x g pellet and supernatant fractions, respectively of 
isolated liver.
FBP - is fructose (bis) 1,6 diphosphate, a known allosteric modifier of liver pyruvate kinase. It was 
used at the following concentration: 10 ul of 10mM solution per cuvette.
* = means are significantly different from values obtained for control animals (P<0.05).
~ = means are signficantly different from pre FBP values (P<0.05).
° = means are significantly different in the ratio between control and activity following FBP 
treatment.
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cytosolic activity by an equivalent amount, i.e. sesbania treatment 
had no effect on the ability of FBP to influence the cytosolic enzyme 
activity (Table 24). In the microsomal fraction FBP caused a 
slightly greater increase in sesbania treated animals than in control 
anim als.
Liver A lkaline Phosphatase:
Table 25 shows the effects of sesbania treatment on the 
activ ities of liver a lka line phosphatase. A lka line phosphatase 
(APase), an enzyme excreted into the serum via the biliary pathway, 
was found to be purely cytosolic in distribution in the livers of both 
chickens and rats (Table 25). Sesbania produced decreases in 
measurable activities in both animal species.
Liver Gamma Glutam yl Transpeptidase:
Liver gamma glutam yl transpeptidase activ ities and the 
influence of sesbania treatment on these activities are shown in 
Table 26. Gamma glutamyl transpeptidase (GGT) activities were 
examined in both chickens and rats. In treated chickens, no changes 
in the activity of this enzyme were noted in either the cytosolic or 
microsomal fractions (Table 26). In the rat, the majority of this 
enzyme was associated with the microsomes. This activity was 
severely reduced following sesbania treatment. The minor cytosolic 
activity was not affected by sesbania treatment in either species.
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TABLE 25
Activity of liver alkaline phosphatase (APase) in chickens and rats 
undergoing sesbania treatment.
Fraction
Alkaline
CHICKEN  
Control Treated
Phosphatase
RAT
Control Treated
Cytosol 2.246
+-0.036
0.812*
+-0.003
0.485
+-0.003
0.299*
+-0 .0 0 1
Microsome Not
detected
Not
detected
Not
detected
Not
detected
Values are the means +- the SEM for n = 26 chickens and n = 12 rats for each group.
Control animals were untreated. Treated animals were dosed for three days, chickens are 1.0% of 
the body weight and rats at 0.5% of the body weight/day.
APase units are expressed as nanomoles of substrate converted per minute per mg of protein at 
22C.
* = means are significantly different from values obtained for control animals (P<0.05).
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TABLE 26
Activities of gamma glutamyl transpeptidase (GGT) in the livers of 
chickens and rats receiving sesbania extracts.
Fraction
Glutamyl Transpeptidase 
CHICKEN RAT 
Control Treated Control Treated
Cytosol 9.247 9.306 10.014 6.731
+-0.257 +-1.108 +-1.334 +-0.703
Microsome 2.225 2.489 31.183 4.624*
+-0.042 +-0.061 +- 0.352 +-0.051
Values are the means +- the SEM for n = 6 animals per group.
Control animals were untreated. All treated animals were dosed for three days, chickens at 1.0% 
of the body weight and rats at 0.3% of the body weight/day.
GGT units are expressed as nanomoles of substrate converted to product per minute per mg of 
protein.
* = means are significantly different from values obtained for control animals (P<0.05).
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G lu ta th io n e -S -T ra n s fe rs a s e s :
In the mature chicken (6-9 weeks of age), m icrosomal 
ligandin (GST-I) activ ity was increased by sesbania ( - 2 0 0 % of
control) and phenobarbital treatments{~2 0 0 % of control) as shown in 
Table 27. The com bination treatm ent with phenobarb ita l and 
sesbania depressed this activity below control values (less than 
25% of control). BNF treatment did not alter the activity of this 
m icrosom al isozyme. The com bination treatm ent of BNF and 
sesban ia  reduced the ac tiv ity  of th is  isozym e in iso la ted 
microsomes (less than 25% of control).
In the mature chicken cytosol, sesbania treatment increased 
the activity of GST-I (387% of control). Phenobarbital treatment 
produced no change in enzyme activ ity, while the com bination 
treatment of phenobarbital and sesbania also increased the activity 
of GST-I (198% of control). This increase by phenobarbital and 
sesbania treatment was less than the increase produced by sesbania 
alone. BNF or BNF and sesbania treatments produced no change in 
the enzyme activity.
In the immature chicken (less than 14 days old), the activity 
of microsomal GST-I was increased by phenobarbital and sesbania or 
BNF treatment alone (Table 27). All other treatments produced no 
effects on enzyme activity. The cytosolic activity of GST-I was 
increased 110% by sesbania treatment, 1389% by phenobarbital 
treatment and 1789% by phenobarbital and sesbania treatment. This 
increase by phenobarbital and sesbania combination treatment was 
simple addition of the two individual treatments. BNF treatment and
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TABLE 27
Activities of GST-1 (iigandin, DNCB) in chicken following sesbania
and/or phenobarbital and/or BNF treatments.
CHICKEN  
Mature Immature
Treatment Microsome Cytosol Microsome Cytosol
Control 0.0114
+-0.0029
0.0061
+-0.0009
0 .0 0 2 2 *
4-0.0002
0.0063-
4-0.0012
Sesbania 0.0260*
4-0.0047
0.0236*
+-0.0070
0.0032*
4-0.0004
0.0132*-
4-0.0008
Phenobarbital 0.0283*
+-0.0052
0.0063-
4-0.0008
0.0036*
4-0.0006
0.0938*-
4-0.0194
Pheno + 
Sesbania
0.0024*A
+-0.0013
0 .0 1 2 1 * 
4-0.0018
0.0077*
4-0.0017
0.1190*-
4-0.0275
BNF 0.0060 A 
+-0 .0 0 0 2
0.0090
4-0.0013
0.0048*
4-0.0003
0.0068
4-0.0012
BNF + 
Sesbania
0 .0 0 2 0 *a
+-0.0004
0.0053-
4-0.0011
0.0045
4-0.0058
0.0087
4-0.0014
Values are the mean +- the SEM for n = 6 animals per group.
Controls were untreated. Chickens were dosed with 80 mg/kg of phenobarbital or 40 mg/kg of 
BNF for three days followed by 1.0% of the body weight/day of a 20K sesbania extract for 2 days 
prior to sacrifice.
* = means are signficantly different from values obtained for control animals (P<0.05).
~ = means of cytosolic values are signficantly different from values obtained for microsomal 
fraction (P<0.05).
° = means of immature values are significantly different from values obtained for mature chickens 
(P<0.05).
A = means are significantly different from values obtained for sesbania treated animals (P<0.05).
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the combination treatement showed little effect on cytosolic GST-I 
a c t iv ity .
The effects of sesbania on GST-II activities are given in 
Table 28. None of the treatment regimens gave values which were 
significantly d ifferent from control values.
The effects of sesbania and other treatm ents on GST-Ill 
activities are given in Table 29. Mature chicken microsomal and 
immature chick cytosolic fraction receiving BNF treatment showed 
increased GST III activ ity. All other treatm ents were w ithout 
effect on G ST-Ill activities.
The activity of mature chicken microsomal GST-IV activity 
was increased by sesbania, phenobarbital and the combination of BNF 
and sesbania (Table 30). The other treatments produced no effects. 
This enzyme activity in mature chicken cytosol was increased by 
BNF and sesbania combination treatments alone. No other changes 
were noted. For the immature chicken only, all treatm ents 
significantly lowered the microsomal activities (sesbania, 3 .3 % of 
control; phenobarbital, 1.90% of control, phenobarbital and sesbania, 
13.5% of control; BNF, 0.3% of control and BNF and sesbania, 1.1% of 
contro l). In the immature chicken cytoso lic  fraction, sesbania 
(543% of control), phenobarbital and sesbania (286% of control) and 
BNF (557% of control) treatments increased GST-IV activity.
Values for rat GST-I microsomal and cytosolic activities are 
shown in Table 31. The mature rat microsomal GST-I activity was 
depressed by BNF. The combination treatment of BNF and sesbania 
failed to reverse the BNF inhibition. O ther treatm ents produced 
activ ities  which were s im ilar to contro l va lues. Mature rat
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TABLE 28
Activities of GST-II (DCNB) in chicken following sesbania and / or 
phenobarbital and / or BNF treatments.
Treatment
CHICKEN  
Mature 
Microsome Cytosol
Immature 
Microsome Cytosol
Control 0.0104 0.0108 0 .0 0 2 1 ° 0.0019°
+-0.0029 +-0.0038 +-0 .0 0 0 2 +-0.0004
Sesbania 0.0105 0.0083 0.0039° 0.0034°
+-0 .0 0 2 2 +-0 .0 0 2 2 +-0 .0 0 1 0 +-0.0007
Pheno- 0.0088 0.0054 0.0018° 0.0028°
barbital +-0.0028 +-0.0009 +-0 .0 0 0 1 +-0.0004
Pheno + 0.0131 0.0079 0.0034° 0.0039°
Sesbania +-0.0044 +-0.0013 +-0.0006 +-0.0008
BNF 0.0083 0 .0 0 1 2 - 0 .0 0 0 1 ° 0.0030°
+-0 .0 0 1 0 +-0 .0 0 0 2 +-0 .0 0 1 2 +-0 .0 0 0 2
BNF + 0.0090 0.0019 0.0008° 0 .0 0 2 1 °
Sesbania +-0.0095 +-0.0004 +-0 .0 0 0 2 +-0.0004
* = means are significantly different from the values obtained for control animals (P<0.05).
~ = means for the cytosolic values are significantly different from values obtained for microsomal 
fractions (P<0.05).
0 = means for immature chicken are significantly different from values obtained for mature chicken 
(P<0.05).
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Activities of GST-ili 
or phenobarbital and
TABLE 29
(NPA) in chickens 
/ or BNF.
treated with sesbania and
Treatment
CHICKEN  
Mature 
Microsome Cytosol
Immature 
Microsome Cytosol
Control 57.05 23.40- 71.34 29.70-
+- 9.20 +- 3.37 +- 5.22 +- 1.93
Sesbania 79.48 18.11- 76.54 28.71-
+-16.87 +- 2 .8 8 +-13.80 +- 3.92
Pheno­ 41.84 15.22- 126.78° 25.20°
barbital +- 5.25 +- 2.03 +- 28.24 +-5.56
Pheno + 155.13 22.33- 89.19 2 2 .1 2 -
Sesbania +- 53.81 +-3.97 +- 20.31 +- 4.70
BNF 138.66* 20.32- 83.96 39.03*-
+- 1 .0 0 +-0.70 +- 8.50 +- 2.35
BNF + 80.85 13.32- 87.09 31.37-
Sesbania +- 3.85 +- 0 .6 8 +- 9.45 +- 1.37
* = means are significanlty different from values obtained for control animals P<0.05).
~ = means for cytosolic fractions are significantly different from values obtained for microsomal 
fractions (P<0.05).
° = means for immature animals are significantly different from values obtained for mature chicken 
(P<0.05).
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TABLE 30
Activities of GST-IV (4BD) in chicken following sesbania and / or
phenobarbital and / or BNF treatments.
Treatment
c h ic k e n
Mature 
Microsome Cytosol
Immature 
Microsome Cytosol
Control 0.0018
+-0.0003
0.0005-
+-0 .0 0 0 1
0.1062°
+-0.0249
0.0007-
+-0 .0 0 0 1
Sesbania 0.0070*
+-0.0028
0.0006-
+-0 .0 0 0 1
0.0035*
+-0.0006
0.0038*°
+-0.0008
Pheno­
barbital
0.0061*
+-0.0015
0.0004-
+-0 .0 0 0 0
0 .0 0 2 0 *
+-0.0004
0.0007-°
+-0 .0 0 0 1
Pheno + 
Sesbania
0.0048
+-0.0018
0.0004-
+-0 .0 0 0 1
0.0143*
+-0.0033
0 .0 0 2 0 *-°
+-0.0003
BNF 0.0030
+-0.0004
0.0006-
+-0 .0 0 0 0
0.0003*°
+-0 .0 0 0 0
0.0039*-°
+-0.0008
BNF + 
Sesbania
0.0073*
+-0.0016
0.0039*
+-0.0008
0 .0 0 1 2 *°
+-0 .0 0 0 2
0.0006-°
+-0 .0 0 0 1
* = means are significantly different from values obtained for control animals (P<0.05).
~ = cytosolic means are significantly different from values obtained for microsomal fractions in the 
chicken (P<0.05).
° = means obtained for immature animals are signifcantly different from values obtained for mature 
chickens (P<0.05).
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TABLE 31
Activities of GST-I (ligandin, DNCB) in rats following sesbania, and 
/ or phenobarbital and / or BNF treatments.
E M
Mature Immature
Treatment Microsome Cytosol Microsome Cytosol
Control 0.0117
+-0.0024
0 .0 1 1 2
+-0.0026
0.0014*
+-0 .0 0 0 2
0.0063-
+-0.0014
Sesbania 0.0055 0.0074 
+-0.0193 +-0.0023
0.0090*
+-0 .0 0 1 0
0.0163*—
+-0 .0 0 2 1
Pheno­
barbital
0.0097
+-0.0018
0 .0 1 2 1
+-0.0016
0.0036**
+-0.0008
0.0014*—
+-0 .0 0 0 1
Pheno + 
Sesbania
0.0140
+-0 .0 0 2 1
0.0136
+-0.0023
0.0067*-
+-0.0007
0.0103
+-0.0023
BNF 0.0014*
+-0 .0 0 0 1
0.0066-
+-0.0014
0.0081**
+-0.0017
0.0179*—
+-0 .0 0 0 2
BNF + 
Sesbania
0 .0 0 1 1 *
+-0 .0 0 0 0
0.0025*-
+-0 .0 0 0 2
0.0068**
+-0.0005
0.0321*-
+-0.0056
* = means are significantly different from values obtained for control rats (P<0.05).
~ = cytosolic values are significantly different from values obtained for microsomal fractions 
(P<0.05).
• = immature values are significantly different from values obtained for mature rats (P<0.05).
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cytosolic activity was depressed by BNF and sesbania treatment, 
even though neither individual treatment had shown an effect. For 
the im m ature rat m icrosom e, all trea tm ents increased GST-I 
activ ity. For im m ature rat cytoso lic GST-I activ ities, sesbania 
alone or in combination produced increased values. BNF treatment 
also produced increased activity, whereas, phenobarbital treatment 
decreased GST-I activ ity . In all com binations treatm ents the 
effects of sesbania were additive to other treatments.
A significant decrease in activity produced by BNF and BNF 
and sesbania treatments on mature rat microsomal GST-II can be 
seen in Table 32. No other treatment caused any change in enzyme 
ac tiv ity . The cy to so lic  ac tiv ities  were depressed by all 
treatements in the mature rat. This effect was least pronounced for 
the combination treatment of phenobabital plus sesbania which was 
not significantly (P>0.05) below values obtained for control animals.
For the immature rat, sesbania, sesbania and phenobarbital, 
BNF or BNF and sesbania treatments significantly (P<0.05) increased 
the activity of microsomal GST-II. Phenobarbital treatment alone 
was w ithout effect. In immature rat cytosol, the combination 
treatm ent of phenobarbita l and sesbania gave GST-II activities 
which were not s ign ifican tly  d iffe ren t from control values, 
although this lack of significance might be due to the large standard 
error obtained. Phenobarbital treatment depressed this activity. All 
other trea tm ents (i.e. sesbania, BNF or BNF and sesbania) 
s ign ifican tly  increased the activ ity  of GST-II in im m ature rat 
cytoso l.
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TABLE 32
Activities of GST-II (DCNB) in rats treated with sesbania and / or
phenobarbital and I or BNF.
RAT
Mature Immature
Treatment Microsome Cytosol Microsome Cytosol
Control 0.0024
+-0.0003
0.0193-
+-0.0024
0.0017
+-0.0013
0.0060-°
+-0 .0 0 1 1
Sesbania 0.0014
+-0 .0 0 0 2
0 .0 1 0 1 *-
+-0.0016
0.0097*°
+-0.0013
0.0183*-°
+-0.0029
Pheno­
barbital
0.0031
+-0.0004
0.0108*-
+-0.0019
0.0033
+-0.0007
0.0016*~° 
+-0.0005
Pheno + 
Sesbania
0 .0 0 2 1
+-0.0048
0 .0 1 2 2 -
+-0.0017
0.0087*°
+-0.0008
0.0093
+-0.0025
BNF 0.0007*
+-0 .0 0 0 1
0 .0 0 1 0 *
+-0 .0 0 0 0
0.0088*°
+-0.0019
0.0182*-°
+-0.0023
BNF + 
Sesbania
0 .0 0 0 2 *
+-0 .0 0 0 0
0 .0 0 2 1 *-
+-0 .0 0 0 1
0.0083*°
+-0 .0 0 1 2
0.0305*-°
+-0.0061
* = means are significantly different from values obtained for control animals (P<0.05).
~ = cytosolic values are significantly different from values obtained for microsomal fractions 
(P<0.05).
° = immature means are significantly different from values obtained for mature rats (P<0.05).
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The effects of sesbania and / or phenobarbital and / or BNF 
trea tm ents on rat G S T-Ill activ ities are shown in Table 33. 
Sesbania, phenobarbital or the combination treatment (sesbania and 
phenobarb ita l) s ligh tly  increased the activ ities  of mature rat
m icrosomal G ST-Ill. BNF alone caused a significant decline in 
activ ity  w hile the com bination of BNF and sesbania was not 
significantly different from control values. The cytosolic enzyme 
activity was unchanged by any treatment. As with the mature rat, 
im m ature m icrosom al activ ities  of G S T-Ill were increased by 
sesbania and phenobarbital. In contrast with the mature values, 
however, treatment with phenobarbital and sesbania gave values 
which were not significantly above control values. Whereas BNF in 
the mature rat caused a decline in GST-Ill activity, BNF or BNF and
sesbania treatm ents increased immature m icrosomal G ST-Ill. No
treatm ent effects were observed for mature cytosolic values, but 
phenobarbita l or phenobarbital and sesbania caused sign ificant 
declines in the activity of this isozyme in immature rats. BNF
treatment caused a significant increase in immature cytosolic GST- 
Ill. The combination treatment was neither additive nor synergistic.
Rat GST-IV activities are shown in Table 34. Phenobarbital, 
BNF or BNF and sesbania treatments caused significant declines in 
the mature rat microsomal GST-IV activities. Sesbania treatment 
had no effect. The cytosolic isozyme was unaffected by any 
treatment. In immature rats, sesbania treatment had no effect on 
enzyme activ ity, but phenobarbita l treatm ent caused significant 
increases in a c tiv itie s  w hereas the com b ina tion  trea tm ent
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TABLE 33
Activities of GST-Ill (NPA) in rats treated with sesbania and / or
phenobarbital and / or BNF.
RAJ
Mature Immature
Treatment Microsome Cytosol Microsome Cytosol
Control 110.89 12.47- 16.52° 69.17
+- 4.99 +-5.85 +- 0.97 +- 6.34
Sesbania 128.67* 14.88- 27.02*° 84.63
+- 2.94 +-1.50 +- 1.73 +-14.05
Pheno­ 124.72* 21.53- 20.70*° 34.43
barbital +- 0.59 +-3.65 +- 0.65 +- 4.36
Pheno + 130.03* 17.76- 15.38° 34.76
Sesbania +- 3.72 +-2.60 +- 1 .0 0 +- 4.06
BNF 86.50* 31.02- 23.90*° 86.53
+-0.39 +-5.39 +- 0.70 +- 0.06
BNF + 103.21 14.07- 21.28*° 75.78
Sesbania +-10.32 +-1.30 +-0 .1 2 +- 0.40
* = means are signficantly different from values obtained for control animals (P<0.05).
~= cytosolic means are significantly different from microsomal fractions in the rat (P<0.05).
° = immature values are significantly different from values obtained for mature rats (P<0.05).
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TABLE 34
Activities of GST-IV (4BO) in rats treated with sesbania and / or
phenobarbital and / or BNF.
RAT
Mature immature
Treatment Microsome Cytosol Microsome Cytosol
Control 0.0044
+-0.0007
0.0003-
+-0 .0 0 0 0
0 .0 0 0 2 °
+-0 .0 0 0 0
0.0014-°
+-0 .0 0 0 1
Sesbania 0.0030
+-0.0067
0.0004-
+-0 .0 0 0 1
0 .0 0 0 1 °
+-0 .0 0 0 0
0.0013-°
+-0 .0 0 0 2
Pheno­
barbital
0.0008*
+-0 .0 0 0 1
0.0006
+-0 .0 0 0 0
0 .0 0 0 1
+-0 .0 0 0 0
0.0044*-°
+-0.0009
Pheno+
Sesbania
0.0028
+-0.0006
0.0005-
+-0 .0 0 0 1
0.0005
+-0 .0 0 0 1
0.0004*
+-0 .0 0 0 1
BNF 0.0007*
+-0 .0 0 0 0
0 .0 0 0 2
+-0 .0 0 0 0
0.0004
+-0 .0 0 0 1
0.0014-°
+-0 .0 0 0 1
BNF + 
Sesbania
0.0007*
+-0 .0 0 0 1
0 .0 0 0 2
+-0 .0 0 0 0
0.0008
+-0.0018
0.0013°
+-0 .0 0 0 1
= means are significantly different from values obtained for control values (P<0.05).
= cytosolic fractions are signficantly different from microsomal fractions in the rat (P<0.05). 
= immature values are significantly different fron values obtained for mature rats (P<0.05).
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(phenobarbital and sesbania) lowered activities. BNF or BNF and 
sesbania had no effect on immature rat cytosolic activity GST-IV.
Cytochrom e P-450 Monooxygenase:
In a prelim inary experim ent with two animals per group, 
sesbania treatm ent was found to increase the concentration of 
cytochrome P-450 in chickens (Table 35) in agreement with previous 
observations by Banton e ia i ,  1987. The sensitivity of the scan did 
not permit differentiation between cytochromes P-450 and P-448.
Liver G luthathione Peroxidase:
G luthath ione peroxidase is an enzyme which helps to 
m ain ta in  m em brane s ta b ility , e sp e c ia lly  by reduc ing  lip id  
peroxidation. Sesbania treatm ent reduced chicken microsomal 
activity by 50%. Both BNF and phenobarbital increased the activity 
in chicken microsomes. These increases were not reduced by 
sesbania pretreatment (Table 36). In the rat, sesbania had no effect 
on this enzyme activity. Only phenobarbital increased microsomal 
glutathione peroxidase activity. This effect was slightly reduced 
when sesban ia  was com bined with the in itia l phenobarb ita l 
pretreatment (Table 36). BNF had no effect on enzyme activity.
The cy toso lic  ac tiv ities  of g lu ta th ione  peroxidase were 
increased in both sesbania treated chickens and rats (Table 37). 
S im ilarly, both BNF and phenobarbital treatm ents increased the 
activity of this enzyme. The effect of BNF and sesbania treatment 
caused a synergistic increase in activity in the chicken but additive
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TABLE 35
The effect of sesbania on the concentration of cytochrome P>450 in 
chicken liver.
CHICKEN
Treatment P-450  
nmole/mg 
microsomal protein
Ratio
Control 0.256 —
Treated 0.732 2.90
Values are the mean of a duplicate liver sample for two animals per group.
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TABLE 36
Microsomal glutathione peroxidase activities in chicken and rats 
receiving either sesbania and / or phenobarbital and / or BNF 
treatments.
GLUTATHIONE PEROXIDASE
Treatment CHICKEN RAT
Control 0.49 2.36
+-0.04 +-0.05
Sesbania 0.23* 2.51
+-0 .01 +-0.06
BNF 0.80 2.17
+-0 .0 0 +-0.05
BNF + Sesbania 1.29* 2.96
+-0 .0 0 +-0.37
Phenobarbital 2.99* 6.30*
+-0.01 +-0.07
Pheno + Sesbania 3.01* 5.05*°
+-0.01 +-0.17
Values are the means +- the SEM for n = 6 animals per group.
Control animals were untreated. Phenobarbital concentration was 80 mg/kg for 3 days, while BNF 
was used at a concentration of 40 mg/kg alone or followed by sesbania (1.0% body weight / day 
for chickens and 0.5% body weight / day for rats) for 2 days.
* = Means are signficantly different from values obtained for control animals (P<0.05).
° = Means are significantly lower than phenobarbital treatment alone (P<0.05).
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TABLE 37
Cytosolic glutathione peroxidase activities in chickens and rats
receiving sesbania and / or phenobarbital and / or BNF treatments.
Treatment
Glutathione
CHICKEN
Peroxidase
RAT
Control 2.99 2.15
+-0 .01 +-0 .11
Sesbania 5.31* 5.94*
+-0 .01 +-0.05
BNF 5.59* 5.47*
+-0 .21 +-0.08
BNF + Sesbania 14.37* 11.59*
+- 0.47 +-0.13
Phenobarbital 11.31* 3.66*
+- 0.44 +- 0.03
Pheno+ Sesbania 13.50* 8.17*
+-0.36 +- 0.05
Values are the means +- the SEM for n = 6 animals per group.
* = means are significantly different from values obtained for control animals (P<0.05).
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in the rat (Table 37). The effect of phenobarbital and sesbania 
treatment was less than additive in both chickens and rats.
Liver G lucose-6-Phosphate Dehydrogenase:
Glucose-6 -phosphate dehydrogenase is a major enzyme in the 
pathway responsible for supplying the cell with reducing power in 
the form of NADPH. In chickens, sesbania produced no changes in 
either microsomal or cytosolic activities of this enzyme (Table 38). 
Sesbania treatment decreased rat microsomal activity but had no 
effect on cytosolic activity (Table 38).
Sulfhydryl Group:
Reduced glutathione is a cofactor in reactions mediated by 
glutathione peroxidase and other important xenobiotic metabolizing 
enzyme systems. Sulfhydryl availability was unchanged in animals 
undergoing sesbania treatment (Table 39).
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TABLE 38
Glucose-6-phosphate dehydrogenase activity in the livers of 
chickens and rats treated with sesbania.
Fraction
C H IC K EN  
Control Treated Control
RAT
Treated
Microsomes 0.08 0 .1 0 0.43 0.27*
+-0 .01 +-0 .0 0 +-0 .0 2 +-0 .0 0
Cytosol 0.08 0 .1 0 0.17 0.16
+-0 .01 +-0 .0 2 +-0 .01 +-0.01
Values are the means +- the SEM for n = 6 animals per group.
Controls were untreated. Rats were dosed at 0.5% of the body weight/day while chickens 
received 1.0% of the body weight/day for three days of a 20K sesbania extract.
* = means are significantly different from the values obtained for control animals (P<0.05).
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TABLE 39
Sulfhydryl group availability as estimated by reduced glutathione
concentration (GSH) in the livers of sesbania treated chickens and
rats.
Fraction
GSH
(lim oles)
CHICKEN  
Control Treated Control
RAT
Treated
Microsomes 0.46 0.51 0.65 0.64
+-0 .0 0 +-0 .0 0 +-0 .0 0 +-0.01
Cytosol 2.76 2.81 2.15 1.99
+-0.04 +-0.07 +-0.04 +-0.01
Values are the means +- the SEM for n = 6 animals per group.
Controls were untreated. Treated rats were dosed at a rate of 0.5% of the body weight / day and 
chickens at 1.0% of the body weight / day for three days.
* = means are significantly different from values obtained for control animals (P<0.05).
DISCUSSION
This study had two major objectives. The first was the 
in itia l iso la tion and iden tifica tion  of the tox ic  princ ip le (s) of 
Sesbania drum m ondii, and the second was to study the 
mechanism(s) of action of these toxin(s) in hepatic tissue. The 
firs t section of th is trea tise  described some of the physical 
characteristics of the toxic principle(s). Though complete isolation 
was not achieved, relevant information regarding temperature, pH 
and general lability of the toxin(s) was obtained. An important 
contribution of this work was the accumulation of evidence that 
supported the postulate that there is more than one major toxin in 
Sesbania drum m ondii.
The separation of toxicity from Sesbania drummondii seeds 
into different pH and molecular weight fractions lent credence to 
the hypothesis that more than one toxin is necessary to account for 
all the physiological effects observed with sesbania poisoning. Heat 
treatment of Sesbania drummondii extracts completely eliminated 
the weight loss produced in treated animals, even though decreases 
in c ircu la ting  serum prote in concen tra tions and lower PChE 
activ ities were still observed. This indicated that the toxin 
responsible for weight loss was heat labile. In contrast, acid 
treatment of extracts (pH 2 supernatant fractions) caused enhanced 
weight loss in treated rats when compared with animals receiving 
the untreated 2 0 K extract. This increase in weight loss was not 
accom panied by increased m orta lity. Extracts of S e s b a n i a
109
110
d r u m m o n d i i  treated with alkali showed the reverse pattern for 
w eight loss and m orta lity . A lka li trea tm ent increased the 
m ortality of treated anim als (pH 8  supernatant fraction) while 
decreasing weight loss. Above pH 10, extract toxic ity declined 
p re c ip ito u s ly .
The seed portion of the plant is highly toxic (Flory and 
Hebert, 1984). Freeze-thawing of an aqueous filtrate of ground 
sesbania seeds disrupted the seed material sufficiently to release a 
previously non-dialyzable toxin from the seeds. This preparation 
produced a larger decrease in both serum protein concentration and 
PChE activity in treated animals when compared with animals dosed 
with unfrozen 20K extract, although it produced less weight loss. 
There is the possibility that the toxin responsible for weight loss is 
cold labile. The results also suggested that in its native state the 
toxin responsible for decreases in serum protein concentration and 
PChE activ ity  was part of a larger m olecular weight complex, 
perhaps non-covalently associated with non-dialyzable material.
The loss in tox ic ity  follow ing passage of 20K extracts 
through agarose, Sephadex™ G-25 or Con A - Sepharose indicated 
that one or more of the sesbania toxins could either be a lectin or 
had the capacity of interacting with carbohydrates. The inability to 
elute these toxic agents with alpha-methyl- glucoside, as we!! as 
the apparent small molecular weight of the toxins (<1000MW using 
hollow fiber and Amicon u ltra filtra tion  fractiona tion), makes a 
p ro te in -le c tin  u n like ly . It is p robab le  tha t e le c tro s ta tic  
interactions between these matrices led to irreversib le binding of 
sesbania toxic principles to the matrices. This phenomenon has been
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well docum ented and is prevalent for the tigh tly  cross-linked 
dextrans as well as for small aromatic compounds (Janson, 1966).
One of the purported toxins from Sesbania d rum m ond ii is 
sesbanimide. It is a small (MW 326), dialyzable, heat and alkali 
lab ile  com pound (Pow ell a i. 1984). Chickens dosed with 
sesbanim ide preparations lost weight, showed reduced circulating 
serum protein concentrations and a dose-related decrease in PChE 
activ ities typical of experim entally induced sesbania intoxication. 
Since sesbanimide had been previously isolated from the seeds of 
Sesbania drum m ondii (Powell g ia i .  1984), there was no reason to 
assume that sesbanim ide would not be present in our extracts. 
Sesbanimide was tentatively detected by both HPLC and thin layer 
chromatography. The major peak of the sesbanimide preparation had 
a retention time of 9.56 minutes and a minor peak at 7.40 minutes. 
This latter peak corresponded quite closely with the major peak in a 
partially purified sesbania extract (7.35 minutes). Pure sesbanimide 
was more toxic when dosed on the basis of equivalent peak heights 
than partially purified extract. Evidence that the extracts contained 
sesbanimide was obtained by thin layer chromatography on charring 
of silica plates with concentrated H2 SO 4 .
If the mechanism of action of sesbanimide is, as proposed by 
Powell g i& L  (1984), mediated by inhibition of protein synthesis, 
then sim ilarities between sesbanimide poisoning and other protein 
synthesis inhib itors should be observed. Inh ib ition of protein 
synthesis has been postulated as the probable mechanism for the 
an tineop lastic  activ ity  of sesbanim ide. Sesbanim ide shares a
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s tru c tu ra l s im ila r ity  to the  p ro te in  sy n th e s is  in h ib ito r, 
cyclohexim ide.
When cycloheximide, a glutaride type antibiotic, was tested 
for its ab ility  to induce sesbania-like intoxication, it was found 
that many of the clinical signs were sim ilar but not identical to 
those observed in birds and rats treated with sesbania extracts. 
Since cycloheximide is an inhibitor of protein synthesis, one would 
expect to observe decreases in both serum protein concentrations 
and PChE activities with this treatment. Such decreases were noted 
in cycloheximde treated animals. Although the results obtained with 
sesbania extracts were sim ilar to those observed for animals 
receiving cyclohexim ide, there were im portant differences. The 
decrease in PChE activ ity  associated with cyclohexim ide was 
independent of dose, whereas in sesbania treated rats, serum PChE 
activity was dose-related until at least day three of dosing (Table 
11B). Decreases in serum protein concentrations, as a result of 
treatm ent, were greater fo r sesbania than for cyclohexim ide 
treatments. Due to the dose relationship, the effects of sesbania 
extracts on the activ ity of PChE in treated animals were more 
specific than would have been produced by a generalized protein 
synthesis inhibitor. The strongest evidence for differences between 
sesban ia  ex trac t and cyc lohex im ide  trea tm ents  cam e from 
h is to lo g ica l and e lectron  m icroscop ic  exam ina tions . W ith 
cycloheximide treatment, liver damage was evident but no damage 
was observed in h isto logical sections from rats dosed with 
sesbania extracts. In those anim als undergoing cyclohexim ide 
treatment, severe vacuolization of the liver was evident. This was
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confirm ed by thin section analysis. C yclohexim ide treatm ent 
produced a complete change in the liver architecture which was not
observed in sesbania treated rats.
Additional evidence for the presence of more than one toxin 
in crude sesbania extracts came from the observation that heating 
the extracts resulted in a com plete loss of the ab ility  of the 
extracts to induce weight loss. However, the heated extracts were
still e ffec tive  in producing decreases in both serum protein
concentration and PChE activity. Also, the slight hemolysis that
was observed was also not consistent with the effects of a protein 
synthesis inhibitor. Hemolysis had not been observed in animals
treated with the known protein synthesis inhibitor, cyclohexim ide. 
It thus appeared that if sesbanim ide's mode of action were the 
inhibition of protein synthesis, sesbanimide could not be the major 
toxic principle even though other toxins have not yet been isolated. 
A d d itio na l physica l ev idence ex is ts  fo r the separa tion  of
sesbanim ide toxic ity from the major toxic ity of crude sesbania 
extracts. Sesbanim ide is not extractable into aqueous fractions, 
whereas most of the toxicity of crude sesbania preparations is
extractable into aqueous fractions.
The most consistent finding in sesbania intoxication was 
severe gastric enteritis in both treated chickens and rats. This 
observa tion , coupled w ith the presence of frequent petechial 
hemorrhages, suggested that a neutral saponin, such as that 
isolated by Robey (1925), could be a causative agent in sesbania 
poisoning. Saponins are extremely irritating substances which can 
cause hemolysis. Hemolysis was noted as a frequent finding in the
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sera obtained from sesbania treated animals. Hematocrits were, 
however, significantly lowered only in treated chickens (Table 15), 
although there was a sta tis tica lly  non-sign ificant decline in the 
sera from sesbania treated rats. Despite the fact that the chicken 
red blood cell is nucleated and retains nuclear metabolic function, it 
apparently lacked the ability to lim it sesbania induced hemolysis. 
The clinical observation of hemolysis supported the hypothesis that 
a saponotoxin may be present in crude extracts of S e s b a n i a  
d r u m m o n d i i  . It is also obvious that not all of the pathological 
find ings of sesbania in toxication can be accounted for by the 
presence of a saponotoxin. Rats were found to be more sensitive 
than chickens to the actions of sesbania extracts, especially in their 
inab ility  to tolerate higher doses. However, rat hematocrits 
remained unchanged, mitigating against the role of a saponotoxin 
as the major toxin in the pathogenesis of sesbania intoxication in 
this species.
The presence of a smooth muscle inhibitor in sesbania has 
been implicated (Venugopalan £ ia i ,  1984). The isolated stomachs 
from sesbania treated rats, as well as the isolated crops of sesbania 
treated birds, showed paralysis. In addition, the gall bladders of 
sesbania treated chickens were engorged. It was unclear whether 
gall b ladder d istension was due to the inh ib ition of smooth 
musculature, an obstruction of the biliary tree or a lack of hormonal 
stimulus to empty since treated birds were anorexic. Obstruction 
of the gall bladder appeared unlikely since the activities of alkaline 
phosphatase and gamma glutamyl transpeptidase in serum from
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treated animats were not d iffe ren tia lly  affected com pared with 
control serum values.
The release of alkaline phosphatase and gamma glutamyl 
transpeptidase (GGT) is strictly governed by passage through the 
biliary tract. During biliary stasis and obstruction, the activity of 
these enzymes in the serum obtained from treated animals would be 
expected to rise significantly above control values. Instead, the 
serum activities of these enzymes were decreased compared with 
values obtained for sera derived from control animals. In the 
chicken, the liver activ ities of gamma glutam yl transpeptidase 
remained unchanged by sesbania treatment. Since the activity of 
this serum enzyme was depressed by sesbania treatment, there may 
be a problem in the release of this export protein from the liver. 
Enzym atic de te rm in a tio ns  of serum  LDH, gam m a g lu tam yl 
transpeptidase and alkaline phosphatase showed that the activities 
of these enzymes were all reduced in response to sesbania 
treatment. This suggested that liver cell damage was not the prime 
mechanism of action for sesbania toxins (Table 19). In addition to 
the decreases in chicken and rat serum GGT activities, the 
decreases in serum albumin concentration in both treated animal 
species reinforces the idea of a potential problem in export protein 
release from the liver as a result of sesbania intoxication.
The concentration of bilirubin in the rat, which possesses no 
gall bladder, was unaffected by sesbania treatment. The lack of any 
changes in the serum bilirubin concentrations of treated rats and 
decreased serum GGT and APase activ ities also indicated that 
biliary stasis was not an essential feature in sesbania poisoning.
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It was of in te rest to determ ine w hether the effect of 
sesbania extracts on AChE and PChE activities were direct. To test 
this hypothesis, pure enzymes were purchased and their activities 
assayed in the presence of sesbania extracts. The activities of the 
pure enzymes, true AChE derived from eel or pseudocholinesterase 
from horse serum, were unaffected by the addition of sesbania 
extracts. These results suggested that the observed decrease in 
PChE activ ities  due to sesbania extracts were ind irect ,and 
therefore decreases in the serum activities of these enzymes can 
not be directly linked to inhibition of enzyme activity.
The observation that sesbania treated animals showed 
extreme abdominal vasodilatation supports the possibility of smooth 
m uscle inh ib ition  in sesbania in tox ica tion . C ard iac muscle 
inhibition might also be a feature of sesbania intoxication. Both 
treated rats and chickens showed flaccid, d ila ted hearts and 
vasodilatation at necropsy. Treated animals had cold extremities, 
although core body temperatures remained normal. This may 
ind icate  periphera l vasoconstric tion  as a resu lt of sesbania 
treatm ent. Cardiac failure, as suggested at necropsy by the 
presence of a flaccid dilated heart may have been responsible for the 
a p p a re n t v a s o c o n s tr ic t io n  of the e x tre m itie s . P e riph e ra l 
vasoconstriction is a method for maintaining blood pressure to the 
vital organs of the body during cardiac insufficiency. Alternatively, 
the abdominal vasodilation may have been severe enough to decrease 
venous re turn  to the heart, re fle x ive ly  causing periphera l 
vasoconstriction. This aspect of sesbania poisoning needs to be 
further e lucidated both in vitro and in vivo. A direct effect on
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heart muscle in response to sesbania can not be elim inated, 
particularly since the heart was frequently flaccid and dilated on 
postmortem examination. The heart would be an obvious choice for 
fu rther h istochem ical and electron m icroscopic exam ination of 
sesbania induced changes.
In the rat, the petechial hemorrhages of the lung may be 
related to the in vitro smooth muscle inhibition of isolated lung 
parenchyma reported by Venugopalan et a[ (1984) in chickens. These 
observations indicated that the lung may be an additional target 
organ for sesbania intoxication, an organ whose response to sesbania 
and its invo lvem ent in the d isease process requires further 
in ves tig a tio n .
One of the characteristics of sesbania intoxication is severe 
weight loss. This is accompanied by a depletion of body fat stores 
and changes in the serum beta lipoprotein concentrations in the 
treated chicken but not the rat. These changes may reflect the 
transport of free fatty acids in the circulation as beta-lipoproteins 
are the normal carrier proteins for free fatty acids. In addition to 
changes in weight and its associated lipid stores, there was also a 
rem arkab le  w asting of the ske le ta l m uscles observed in 
experim enta lly induced sesbania poisonings. In the fowl, the 
pecto ra l m uscles w ere fre q u e n tly  dark and w asted with 
accompanying petechial hemorrhages. This observation suggested 
the possibility of direct skeletal muscle involvement as a feature of 
sesbania in toxication. Smooth muscle inh ib ition by sesbania 
extracts has previously been noted (Venugopalan et a l. 1987). 
Similar but less dramatic changes were noted in sesbania treated
118
rats. The rats were given 1/2 the dose of treated chickens, so these 
species differences may have been dose related rather than true 
species variations. Taking into consideration the observation that 
sera from sesbania treated chickens or rats had, on average, about 
one half the protein concentration (by im m unodiffusion) of the 
control animals, it is probable that the concentrations of alpha 2 and 
beta 1 fractions remained unchanged while those of albumin fell 
precipitously. When lipids are freed from the adipose cell, they are 
carried in the blood e ither bound to album in or to specific 
lipoproteins, HDL and VLDL (Guyton, 1981). Hence the beta-1 
fraction would be anticipated to increase in response to a need to 
have protein carriers for the free fatty acids released from adipose 
tissue. A specific increase in the concentration of beta-1 fraction 
in the chicken but not the rat (which received a lower dose) might be 
attributable to an increase in the concentration of circulating beta 
lipoproteins. The function of prealbumin is unknown. In the mouse, 
it is a sex dependent protein. Nevertheless, the appearance of a high 
proportion of this protein in the serum of sesbania treated rats 
indicated that there was an alteration in the synthesis and release 
of this export protein from the liver.
The initial observation made by Flory and Hebert (1984), that 
depleted circulating serum protein concentrations are a consequence 
of sesbania treatment, suggested the liver as a possible target 
organ fo r sesbania in tox ica tion . Many serum prote ins are 
synthesized in the liver. The observed decrease in circulating serum 
proteins could therefore be due to either an inhibition of protein 
synthesis or to an inhibition of export protein release from the liver.
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To diffe rentiate between these two possib ilities, both serum and 
liver activities of representative enzymes and comparative levels of 
serum proteins were evaluated.
it is p lausib le  tha t sesbanim ide, due to its proposed 
s im ilarity of action to cyclohexim ide (Powell e ia i ,  1984), m ight 
decrease serum protein concentration by in terfering with protein 
synthesis. However, d iffe ren tia l changes in enzyme activ ities 
rather than a generalized decrease were seen in reponse to sesbania 
trea tm ent : som e g lu ta th ion e -S  -tra n s fe ra se  isozym es were
elevated, others remained unchanged, glutathione peroxidase was 
elevated while PChE, APase, LDH and PK were decreased. Protein 
syn th e s is  in h ib ito rs  shou ld  n o n -s e le c tiv e ly  de crea se  the 
concentrations of all proteins. The rapidity of this effect depends 
on the protein turnover rate. There was no uniform inhibition of 
protein synthesis in sesbania treated animals. In liver fractions 
from trea ted  anim als, the ac tiv ities  of some g lu ta th ione -S  - 
transfe rase isozym es rose s ign ifican tly  w hile  others remained 
unchanged or decreased. Glutathione peroxidase activities, however, 
were lowered in the treated chicken but unchanged in the treated 
rat (Table 37).
The results are not consistent with the hypothesis that 
sesbania extracts caused inhibition of general protein synthesis. 
Inhibitors of protein synthesis should depress the activities of all 
enyzmes to some degree. Differences in protein concentrations or 
the measured enzyme activities in response to sesbania treatment, 
might be explained by different protein turnover rates. If protein 
turnover rates were prolonged, this would account for the apparent
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lack of in fluence of sesbania on certa in enzymes. However, 
increased enzyme activities can only be accounted for by either an 
inhibition of a degradation pathway or an induction of the enzyme. It 
has recently been suggested that inductions of cytochrome P-450 
involve both an increase in synthesis and a simultaneous decrease 
in the enzymes responsible for the degradation of the cytochrome 
(Watkins e iaL , 1986)
Increases in the alpha 2 m acroglobulin fraction normally 
reflect an acute, stressful condition. It is not d ifficu lt to imagine 
that sesbania intoxication is an acutely stressful state. There is a 
marked wasting of both muscle and body fat as well as severe 
depletion of serum proteins. However, acute inflammation is not an 
accompanying feature of sesbania intoxication. In support of this 
is the observation that GGT activ ities are not elevated during 
sesbania treatment. It has been suggested (Singh et a i , 1986) that 
this enzyme is a biochemical marker for inflammatory processes 
and tha t a d irect re la tionsh ip exists between increasing GGT 
activ ity and inflam m ation. Thus the acute stress of sesbania 
intoxication (alpha 2 macroglobulinemia) is probably no+ associated 
with inflam m ation. These results suggested that either sesbania 
toxins are small m olecular weight compounds [previously noted] 
incapable of initiating an inflammatory response or that sesbania 
inhibits the body from producing an inflammatory reaction. In this 
regard, it is relevant to note that the gamma globulin fractions of 
serum were depressed in both chickens and rats undergoing sesbania 
tre a tm e n t.
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Changes were noted in the potassium balance of treated 
chickens. The lack of any change in the potassium concentration of 
treated rats may have been a function of the lower dose that rats 
received because of their greater susceptibility to sesbania toxins. 
Potassium has multifold functions in the body. These include the 
m aintainence of acid-base balance, osm otic presssure and cell- 
m em brane p o te n tia ls  (G uyton , 1981). W hen po tass ium  
concentrations are lowered, impaired nerve cell transmission can 
cause muscular paralysis. Sesbania treated birds showed muscular 
weakness and lethargy. These symptoms are seen with both 
hypokalemia and sesbania intoxication. The most important signs 
normally associated with changes in potassium are changes in the 
cardiac muscle. Decreased potassium in sesbania treated chickens 
may have contributed s ign ificantly to the faccid d ila ted hearts 
observed at necropsy. Changes in potassium concentration may be of 
importance to the overall pathology of sesbania poisoning in the 
chicken. It remains an area where therapeutic intervention is 
p lausib le .
D e creases  in the a c tiv ity  of g lu co se -6 -p h o sp h a te  
dehydrogenase could lead to a decrease in reducing power in the 
form of NADPH. NADPH is a product of glucose-6-phosphate 
dehydrogenase and acts as a co-factor in glutathione peroxidase 
activity. The decrease in the activity in the dehydrogenase may have 
been responsible for the slight hemolysis induced by sesbania since 
the peroxidase is thought to protect against membrane damage. 
However, the activity of glutathione peroxidase was also depressed 
when assayed in vitro in the presence of suffic ient co-factors
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(NADPH and GSH). Reduced glucose-6-phosphate dehydrogenase 
activity may also influence protein synthesis by decreasing supplies 
of needed RNA intermediates. This enzyme catalyzes the initial step 
in the pentose phosphate shunt which produces ribose and ribulose. 
The shunt is a reversible enzyme system which would also supply 
RNA interm ediates from the g lyco lytic  pathway in the form of 
g luco se -6 -ph osph a te  w hich is converted  to the necessary 
biosynthetic pentoses, ribose and ribulose. However, evidence was 
obtained that carbohydrate metabolism was also altered in sesbania 
intoxication. Pyruvate kinase activities were found to be depressed 
by sesbania, although chicken serum glucose concentrations were 
maintained during the course of sesbania treatment. The activity of 
hexokinase for the conversion of glucose to the phosphorylated sugar 
was not assessed.
Since so many of the liver enzyme profiles were found to be 
altered by sesbania treatment and the liver is a major detoxification 
organ of the body, the influence of sesbania treatm ent on the 
m icrosom al m onooxygenase system  was exam ined. Some 
conclus ions as to the nature of the toxins in teracting with 
cytochrome P-448 may be drawn. In a single experiment, sesbania 
was found to increase the concentration of cytochrome P-450. The 
activ ity  of p-n itroanisole was unchanged by sesbania whereas 
resorufin ether oxidation (a specific P-448 mediated reaction) was 
increased by sesbania treatment in the chicken (Banton et a l. 1988). 
A basic assumption is that the interaction of sesbania toxins with 
cytochrome P-448 is direct and that this interaction results in the 
induction of cytochrome P-448 mediated activity. The substrate
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specific ities of cytochrom e P-448 d iffe r substantially from the P- 
450 isomer (Lewis Mai, 1986). Cytochrome P-450 metabolizes 
large, bulky more hydrophillic compounds while cytochrome P-448 
interacts essentia lly with planar (such as sesbanim ide), aromatic 
(not sesbanim ide), highly lipophillic compounds (inconsistent with 
the aqueous extractability of sesbania toxins) [Lewis M al, 1986]. 
The d istribution of the two cytochrom es is genetically controlled 
(P-448 occurring in most tissues, P-450 being predom inately 
confined to hepatocytes). The most specific substrate for the 
determ ination of cytochrome P-448 activ ity is 7-ethoxy resorufin 
(Lewis e i  al. 1986). Substrates for cytochrome P-448 are planar, 
rigid molecules with large size but small depth. In contrast, 
substrates for cytochrome P-450 are non-planar and exhibit greater 
flexib ility of conformation. Inhibitors may act either at the active 
site or may bind to the heme moiety of the cytochrome. Binding to 
the heme portion of the molecule prevents both the binding and 
activation of oxygen. Thus, the substrate can not be oxygenated 
(Lewis Mai, 1986). Many of the inhibitors which bind the heme 
moiety also meet the structural requirements for a substrate. This 
indicates that the active site is an alternate site for interaction 
with the cytochrome. Lewis Mai (1986) have postulated, through 
the use of specific substrates and inhibitors that the active site of 
cytochrome P-448 is in close proximity to the heme moiety of this 
isomer.
Induction of cytochrome P-448 requires a coplanar molecule 
and a cytosolic binding receptor protein (Lewis M a i,  1986). There 
is a direct relationship between the degree of binding of an inducer
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to this cytosolic protein receptor and the amount of subsequent P- 
448 induction. Furthermore, interactions with cytochrome P-448, in 
contrast with cytochrom e P-450 (de tox ifica tion), alm ost always 
lead to increased toxicity (metabolic activation; Lewis et al. 1986). 
It would be of interest to know whether the induction of cytochrome 
P-448 activity by sublethal doses of sesbania could lead to the 
prom otion of tum origenes is  on subsequent exposure to a 
procarcinogen.
The glutathione-S- transferases are a group of isozymes that 
possess ac tiv ity  aga inst hydrophobic, e lec troph ilic  substrates. 
These isozymes possess both delta5 3-ketostero id isomerase and 
glutathione peroxidase activities. These enzymes also participlate 
in the non-covalent binding of heme and bilirubin (Yeung and Gidari,
I980). In the chicken, as in the rat, the binding of heme by cytosolic 
g l u t a t h i o n e - S -  trans fe rase s  may m odu la te  the in tra ce llu la r 
concentration of the microsomal monooxygenase system. At least 
four soluble (cytosolic) binding proteins have been identified in the 
adult hen, although chickens reportedly have lower concentrations of 
microsomal proteins than do rats (Erlich and Larsen, I973). Our 
results showed that on a milligram of protein per gram of liver 
basis, chickens had a higher concentration of both microsomal and 
cytosolic protein than did rats. On the basis of total protein, 
sesbania treatm ent increased the concentration of chicken liver 
cytosolic protein, whereas in rats sesbania treatm ent specifically 
increased the microsomal protein fraction. The drug metabolizing 
capacity of the adult hen differs from that of the rat across a 
spectrum of microsomal enzymes. Chickens are more enzymatically
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mature than rats at two weeks of age. Induction of N-demethylation 
of am inopyrene increased two-fo ld in chickens treated with 3- 
methylcholanthrene compared with no induction in rats of the same 
age (Buynitzky M M , 1978). However, the cytosolic g lutath ione-S- 
transferase ac tiv ities  were reported ly equ iva len t (Erlich M M .,
1981). A lso, Erlich and Larsen (1983) reported tha t BNF 
pretreatm ent increased the activity of g lutath ione-S - transferase 
which remained elevated for at least 96 hours. Pretreatment of 
chicken with BNF increased the specific activity of the GSH-T which 
is important in aflatoxin metabolism. On the other hand, in the rat, 
BNF was less effective at inducing aniline hydroxylase activity than 
in the chicken (Erlich and Larsen, I983).
In the m ature ch icken , sesban ia  and phenobarb ita l 
significantly increased GST-I microsomal activity. The microsomes 
from control animals represented the major site of this isozyme, 
although equivalent microsomal and cytosolic activities were found 
fo llow ing  sesban ia  trea tm ent. In con tras t, the com bination  
treatm ent of phenobarb ita l plus sesbania caused a s ign ifican t 
decline in microsomal activity compared with control values (Table 
27). A plausible explanation for this reversal could be that the 
combination treatm ent induced GST-I activity while simultaneously 
increasing the degradation (turnover rate) of this isozyme in the 
m ic rosom a l fra c tio n . An a lte rn a tiv e  p o s s ib ility  is tha t 
phenobarbital and sesbania might induce slightly different forms of 
GST-I and when sesbania is added fo llow ing phenobarbita l 
pretreatment, it either binds more tightly with the enzyme, making 
it unavailable for the subsequent metabolism of DNCB, or makes an
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unstable enzyme-toxin adduct which is more readily degraded. Such 
a hypothesis has been proposed fo r some substra tes of the 
microsomal monooxygenase system (Lewis M a i,  1986) and might 
also hold true for GSTI.
In the cytosol of the mature chicken, sesbania induced GST- 
1 activity, but phenobarbital had no effect. The activity of this 
isozyme following the combination treatment of phenobarbital plus 
sesbania was significantly lower than the activity from sesbania 
treated animals. This suggested that there were subtle differences 
between the cytosolic and microsomal enzymes, with respect to 
their susceptib ilities to induction by phenobarbital. The effect of 
com bination treatment, as seen in microsomes, may change the 
turnover rate of the enzyme or may not permit the sesbania induced 
increases in enzyme activities or may decrease enzyme synthesis or 
may influence the production of functional enzyme.
This is the first report of microsomal GST-Ill or GST-IV in 
either chickens or rats. These additional enzyme activities may play 
a crucial role in controlling the microsomal monooxygenase system 
by manipulating the available heme.
The influence of age on the induction of g lutath ione-S- 
transferase activities by sesbania was determined in both immature 
(< 2weeks) and mature chickens (>6 weeks). D ifferences were 
observed between the two groups in the ir response to sesbania 
treatment. Development of the microsomal enzyme appeared to take 
longer than that of the cytosolic enzyme, suggesting that they were 
under separate genetic controls. This may also explain why the 
cytosolic enzyme was refractory to phenobarbital in the mature
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chicken. The immature cytosolic enzymatic activity was extremely 
sensitive to phenobarbital induction. In the immature chicken, the 
com bination treatm ent was additive. This suggested that sim ilar 
forms of the enzyme were being induced by both treatments and that 
in the older chicken there was greater specificity of inducer.
BNF is a known inducer of cytochrom e P-448 in chickens. 
Both sesbania and BNF treatm ents induced the resorufin ether 
activ ity of cytochrome P-448 (Banton et a l. 1988) and GST-IV 
activity. GST-IV is an isozyme that is capable of metabolizing alpha 
beta unsaturated ketones the molecular form of one of the known 
conform ers of sesbanim ide. The induction of these activ ities by 
both sesbania and BNF may indicate a possible degradative pathway 
for at least one of the toxins. However, GST-IV activity was not 
increased in the rat and the induction  of the m icrosom al 
monooxygenase system cannot be taken as direct evidence that the 
inducer can be a substrate for this important detoxification system.
Lipid peroxidation and the resultant membrane instability which 
accompanies this phenomenon are most frequently associated with 
the presence or production of strong electrophiles which interact 
with membrane lipids via a free radical mechanism. One of the 
prime functions of glutathione peroxidase is to maintain membrane 
integrity, especially by reducing lipid peroxidation. The reaction of 
glutathione peroxidase depends on two co-factors: NADPH supplied 
by glucose-6-phosphate dehydrogenase (G-6-P-DHase) and GSH. In 
the chicken the activity of G-6-P-DHase was depressed by sesbania 
treatm ent while GSH concentration was unaffected. Both BNF and 
p h e n o b a rb ita l p re trea tm en ts  reve rsed  the sesban ia  induced
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decrease in GSH-peroxidase activity. However, in the rat, induction 
was dependent on phenobarb ita l pretreatm ent and affected the 
m icrosomal enzyme activ ity  exclusively . The induction of this 
enzyme in the cytosolic fraction following sesbania treatment may 
reflect an induction in response to sesbania induced damage 
(presumably via a free radical mechanism).
Future research should be directed at determ ining the major 
enzymes involved in the de tox ifica tion  of sesbania toxins. In 
addition to studying the interactions of purified toxins with isolated 
m icrosom al m onooxygenase system s, the role of free radical 
generation by these toxins needs to be investigated. This will help to 
estab lish  the m echanism  of tox ic ity  and the m echanism  of 
elim ination for the sesbania toxins. Research should be continued 
with respect to the iso la tion and further characterization of the 
toxin. Evidence has been presented in this work to establish that 
there is more than one toxin in crude extracts of S e s b a n i a  
drummondii. Physical separation of the toxin responsible for 
weight loss from the toxin responsible for mortality, as observed in 
pH 2 treated extracts, could have economic potential as a possible 
therapeutic agent for excess obesity with a high safety index.
Studies on lung and heart as possible major target sites for 
sesbania intoxication need to be performed. The gross pathological 
findings of petechial hemorrhages (lung) and flaccid dilated hearts 
will require the use of histological techniques to better define the 
problem. The role of electrolytes in the pathophysiology of sesbania 
intoxication also merits investigation. Electrolyte imbalance, as an 
adjunct factor in accidental poisoning of cattle, needs to be furthur
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elucidated. The life threatening electrolyte a lterations observed in 
experim entally poisoned chickens may be instrumental in explaining 
the rapid death that is observed. Electrolyte imbalance is an area 
where therapeutic intervention is possible and could be a decisive 
factor in recovery from sesbania intoxication.
To summarize, this work supports the presence of more than 
one toxin in crude extracts of sesbania. This hypothesis is based 
primarily on the observation that the separation of different clinical 
signs could be achieved by manipulating physical parameters. Also, 
the results in the study diminish the possibilty that sesbanimide is 
the major toxin of Sesbania d rum m ond ii.
This work establishes the liver as a prime target organ for 
sesbania induced toxicity, although other organs are also involved, 
especially the card iac and respiratory systems. Sesbania toxins 
depress the concen tra tion  of serum pro te ins and se lective ly  
diminish the release of export proteins as indicated by at least one 
enzymatic activity. This work also describes the presence of at 
least two new m icrosom al g lutath ione-S -transferases which have 
hitherto not been identified. Initial indications suggest that one of 
the ta rge t sites in the liver is the m icrosom al monooxygenase 
system. These results have also indicated that there are strong 
species differences between chickens and rats in their responses to 
sesbania in toxication.
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